STOCK TITAN

Cemtrex (CETX) posts Q2 2026 profit, adds acquisitions amid going concern risk

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
10-Q

Rhea-AI Filing Summary

Cemtrex, Inc. reported results for the quarter ended March 31, 2026 with revenue of $18.1 million, down from $27.3 million a year earlier, but posted net income attributable to stockholders of $907,048, largely influenced by non‑operating items.

For the first six months of fiscal 2026, revenue was $34.2 million versus $41.0 million in the prior‑year period, and Cemtrex recorded a net loss of $19.6 million. Cash used in operating activities was $5.3 million, while financing activities provided $20.9 million, including a $10.0 million equity offering and warrant exercises.

The company completed two acquisitions: Invocon, Inc. for cash consideration of $7.06 million (recognizing $3.98 million of goodwill and $3.13 million of intangible assets) and the assets of Richland Industries LLC with total preliminary consideration of $5.44 million and a recorded bargain purchase gain of $2.07 million.

Despite ending the quarter with $7.9 million in cash, cash equivalents and restricted cash and total assets of $70.7 million, management disclosed that recurring large net losses, including $28.1 million in fiscal 2025 and substantial debt obligations of $10.8 million due over the next fiscal year, raise substantial doubt about Cemtrex’s ability to continue as a going concern.

Positive

  • Strategic acquisitions expand scale and segments: Cemtrex acquired Invocon, Inc. for total consideration of $6.67 million and Richland assets for $5.44 million, adding an Aerospace and Defense segment, a Tennessee fabrication platform, $3.98 million of goodwill and $3.13 million of intangibles, plus a $2.07 million bargain purchase gain.
  • Meaningful equity and warrant capital raised: During the six months ended March 31, 2026, Cemtrex raised $10.0 million in gross proceeds from an equity offering and $5.68 million from Series B warrant exercises, materially increasing additional paid‑in capital to $151.3 million and boosting total stockholders’ equity to $34.7 million.

Negative

  • Explicit going concern warning with heavy near‑term debt: Management cites substantial doubt about Cemtrex’s ability to continue as a going concern, pointing to six‑month net losses of $19.6 million, prior‑year loss of $28.1 million, and debt obligations of $10.8 million due over the next fiscal year.
  • Cash burn and reliance on non‑cash financing: Operating activities used $5.31 million of cash over six months, while support came from financing, including a $7.03 million note bearing additional one‑time interest of $1.05 million and $11.8 million of interest expense settled in equity, highlighting dependence on capital markets.

Insights

Q2 shows acquisitions and capital raises, but going concern risk remains high.

Cemtrex’s balance sheet expanded to $70.7M of assets as of March 31, 2026, driven by the Invocon and Richland acquisitions. Equity rose to $34.7M, helped by a $10.0M equity offering and $5.7M from Series B warrant exercises.

However, the company reported a six‑month net loss of $19.6M, cash used in operations of $5.3M, and relies heavily on non‑cash items such as $11.8M of interest expense paid in equity shares and warrant liability re‑measurements. Near‑term debt obligations of $10.8M and a large $8.3M note contribute to leverage pressure.

Management explicitly states that recurring losses and upcoming maturities raise “substantial doubt” about Cemtrex’s ability to continue as a going concern for one year after issuance of these statements. While the available cash, marketable securities, and a Vicon credit line provide some flexibility, execution of capital‑raising plans will be crucial to addressing obligations.

Q2 2026 Revenue $18,061,367 For the three months ended March 31, 2026
Q2 2025 Revenue $27,250,269 For the three months ended March 31, 2025
Six‑month Net Loss 2026 $19,649,099 Net loss for six months ended March 31, 2026
Cash, cash equivalents and restricted cash $7,910,118 Balance at March 31, 2026
Debt due next fiscal year $10,806,016 Debt obligations over the next fiscal year cited in going concern
Invocon consideration $6,670,807 Total consideration transferred for Invocon after cash acquired
Richland consideration $5,443,888 Total preliminary consideration for Richland assets
Equity raised in offering $10,000,000 Gross proceeds from equity offering in six months ended March 31, 2026
going concern financial
"these conditions and debt obligations over the next fiscal year of $10,806,016 ... raise substantial doubt with respect to the Company’s ability to continue as a going concern"
A going concern is a business that is expected to continue its operations and meet its obligations for the foreseeable future, rather than shutting down or selling off assets. This assumption matters to investors because it indicates stability and ongoing profitability, making the business a more reliable investment. Think of it as believing a restaurant will stay open and serve customers, rather than closing down suddenly.
bargain purchase gain financial
"Bargain purchase gain | 2,068,047 ... Gain/(loss) on exercise of warrant liabilities"
A bargain purchase gain happens when a buyer acquires another company's assets for less than those assets' estimated fair value, producing an immediate accounting profit for the buyer. For investors, it matters because that one-time gain boosts the acquirer's reported earnings and can signal a very favorable deal — like finding a valuable item at a steep discount — but it may also prompt scrutiny about whether asset values or the deal terms were estimated correctly.
warrant liabilities financial
"Warrant liabilities | 743,499 ... Changes in fair value of warrant liability"
Warrant liabilities are the financial obligations a company records when it grants warrants—special rights allowing someone to buy shares at a set price in the future. If the warrants are expected to be exercised, they are treated as a liability because the company might need to deliver shares or cash later. This matters to investors because it affects the company’s reported financial health and the potential dilution of existing shares.
Solana (SOL) financial
"the Company invested $998,642, and 1,000,567, respectively, in Solana (SOL) and staked our holdings"
Solana (SOL) is a digital currency used within a blockchain platform designed to enable fast and inexpensive online transactions. It functions like digital cash that helps power decentralized applications and services, making it important for investors interested in new technology-driven financial tools. Its speed and low costs aim to attract users and developers, potentially increasing its value over time.
simple agreement for future equity (SAFE) financial
"made additional $50,000 in investments on each respective date, via a simple agreement for future equity (“SAFE”) in MasterpieceVR"
Multi-Period Excess Earnings Method (MPEEM) financial
"the Multi-Period Excess Earnings Method (“MPEEM”) is typically applied when the subject intangible asset is the primary driver of earnings"
Revenue $18,061,367
Net income (quarter) $907,048
Six‑month revenue $34,194,678
Six‑month net loss $19,649,099
false --09-30 Q2 0001435064 0001435064 2025-10-01 2026-03-31 0001435064 2026-05-13 0001435064 2026-03-31 0001435064 2025-09-30 0001435064 us-gaap:NonrelatedPartyMember 2026-03-31 0001435064 us-gaap:NonrelatedPartyMember 2025-09-30 0001435064 us-gaap:RelatedPartyMember 2026-03-31 0001435064 us-gaap:RelatedPartyMember 2025-09-30 0001435064 us-gaap:PreferredStockMember 2026-03-31 0001435064 us-gaap:PreferredStockMember 2025-09-30 0001435064 us-gaap:SeriesCPreferredStockMember 2026-03-31 0001435064 us-gaap:SeriesCPreferredStockMember 2025-09-30 0001435064 CETX:SeriesOnePreferredStockMember 2026-03-31 0001435064 CETX:SeriesOnePreferredStockMember 2025-09-30 0001435064 2026-01-01 2026-03-31 0001435064 2025-01-01 2025-03-31 0001435064 2024-10-01 2025-03-31 0001435064 us-gaap:PreferredStockMember CETX:SeriesOnePreferredStockMember 2025-09-30 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2025-09-30 0001435064 us-gaap:CommonStockMember 2025-09-30 0001435064 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001435064 us-gaap:RetainedEarningsMember 2025-09-30 0001435064 us-gaap:TreasuryStockPreferredMember 2025-09-30 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-30 0001435064 us-gaap:PreferredStockMember CETX:SeriesOnePreferredStockMember 2025-12-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2025-12-31 0001435064 us-gaap:CommonStockMember 2025-12-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001435064 us-gaap:RetainedEarningsMember 2025-12-31 0001435064 us-gaap:TreasuryStockPreferredMember 2025-12-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001435064 2025-12-31 0001435064 us-gaap:PreferredStockMember CETX:SeriesOnePreferredStockMember 2024-09-30 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2024-09-30 0001435064 us-gaap:CommonStockMember 2024-09-30 0001435064 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001435064 us-gaap:RetainedEarningsMember 2024-09-30 0001435064 us-gaap:TreasuryStockPreferredMember 2024-09-30 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001435064 2024-09-30 0001435064 CETX:MinorityInterestMember 2024-09-30 0001435064 us-gaap:PreferredStockMember CETX:SeriesOnePreferredStockMember 2024-12-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2024-12-31 0001435064 us-gaap:CommonStockMember 2024-12-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001435064 us-gaap:RetainedEarningsMember 2024-12-31 0001435064 us-gaap:TreasuryStockPreferredMember 2024-12-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001435064 2024-12-31 0001435064 CETX:MinorityInterestMember 2024-12-31 0001435064 us-gaap:PreferredStockMember CETX:SeriesOnePreferredStockMember 2025-10-01 2025-12-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2025-10-01 2025-12-31 0001435064 us-gaap:CommonStockMember 2025-10-01 2025-12-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2025-10-01 2025-12-31 0001435064 us-gaap:RetainedEarningsMember 2025-10-01 2025-12-31 0001435064 us-gaap:TreasuryStockPreferredMember 2025-10-01 2025-12-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-10-01 2025-12-31 0001435064 2025-10-01 2025-12-31 0001435064 us-gaap:PreferredStockMember CETX:SeriesOnePreferredStockMember 2026-01-01 2026-03-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2026-01-01 2026-03-31 0001435064 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001435064 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001435064 us-gaap:TreasuryStockPreferredMember 2026-01-01 2026-03-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-03-31 0001435064 us-gaap:PreferredStockMember CETX:SeriesOnePreferredStockMember 2024-10-01 2024-12-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2024-10-01 2024-12-31 0001435064 us-gaap:CommonStockMember 2024-10-01 2024-12-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2024-10-01 2024-12-31 0001435064 us-gaap:RetainedEarningsMember 2024-10-01 2024-12-31 0001435064 us-gaap:TreasuryStockPreferredMember 2024-10-01 2024-12-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-10-01 2024-12-31 0001435064 2024-10-01 2024-12-31 0001435064 CETX:MinorityInterestMember 2024-10-01 2024-12-31 0001435064 us-gaap:PreferredStockMember CETX:SeriesOnePreferredStockMember 2025-01-01 2025-03-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2025-01-01 2025-03-31 0001435064 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001435064 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001435064 us-gaap:TreasuryStockPreferredMember 2025-01-01 2025-03-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001435064 CETX:MinorityInterestMember 2025-01-01 2025-03-31 0001435064 us-gaap:PreferredStockMember CETX:SeriesOnePreferredStockMember 2026-03-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2026-03-31 0001435064 us-gaap:CommonStockMember 2026-03-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001435064 us-gaap:RetainedEarningsMember 2026-03-31 0001435064 us-gaap:TreasuryStockPreferredMember 2026-03-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0001435064 us-gaap:PreferredStockMember CETX:SeriesOnePreferredStockMember 2025-03-31 0001435064 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2025-03-31 0001435064 us-gaap:CommonStockMember 2025-03-31 0001435064 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001435064 us-gaap:RetainedEarningsMember 2025-03-31 0001435064 us-gaap:TreasuryStockPreferredMember 2025-03-31 0001435064 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001435064 2025-03-31 0001435064 CETX:MinorityInterestMember 2025-03-31 0001435064 us-gaap:CommonStockMember 2024-10-02 2024-10-02 0001435064 us-gaap:CommonStockMember 2024-11-26 2024-11-26 0001435064 us-gaap:CommonStockMember 2025-09-29 2025-09-29 0001435064 CETX:SharePurchaseAgreementMember 2026-01-08 2026-01-08 0001435064 us-gaap:AcquisitionRelatedCostsMember CETX:InvoconIncMember 2026-01-01 2026-03-31 0001435064 us-gaap:AcquisitionRelatedCostsMember CETX:InvoconIncMember 2025-10-01 2026-03-31 0001435064 us-gaap:AcquisitionRelatedCostsMember CETX:InvoconIncMember 2026-03-31 0001435064 us-gaap:AcquisitionRelatedCostsMember CETX:InvoconIncMember 2025-01-01 2025-03-31 0001435064 us-gaap:AcquisitionRelatedCostsMember CETX:InvoconIncMember 2024-10-01 2025-03-31 0001435064 us-gaap:AcquisitionRelatedCostsMember CETX:InvoconIncMember 2025-03-31 0001435064 CETX:RichlandIndustriesLLCMember 2026-02-05 2026-02-05 0001435064 CETX:RichlandIndustriesLLCMember 2026-02-05 0001435064 CETX:FultonBankMortgagePayableMember 2026-02-05 0001435064 CETX:FultonBankMortgagePayableMember 2026-02-05 2026-02-05 0001435064 us-gaap:AcquisitionRelatedCostsMember CETX:RichlandIndustriesLLCMember 2026-01-01 2026-03-31 0001435064 us-gaap:AcquisitionRelatedCostsMember CETX:RichlandIndustriesLLCMember 2025-10-01 2026-03-31 0001435064 us-gaap:AcquisitionRelatedCostsMember CETX:RichlandIndustriesLLCMember 2026-03-31 0001435064 us-gaap:AcquisitionRelatedCostsMember CETX:RichlandIndustriesLLCMember 2025-01-01 2025-03-31 0001435064 us-gaap:AcquisitionRelatedCostsMember CETX:RichlandIndustriesLLCMember 2024-10-01 2025-03-31 0001435064 us-gaap:AcquisitionRelatedCostsMember CETX:RichlandIndustriesLLCMember 2025-03-31 0001435064 2024-10-01 2025-09-30 0001435064 2023-10-01 2024-09-30 0001435064 2026-01-08 0001435064 2026-01-08 2026-01-08 0001435064 2026-02-05 0001435064 2026-02-05 2026-02-05 0001435064 CETX:InvoconIncMember 2026-01-01 2026-03-31 0001435064 CETX:InvoconIncMember 2025-01-01 2025-03-31 0001435064 CETX:InvoconIncMember 2025-10-01 2026-03-31 0001435064 CETX:InvoconIncMember 2024-10-01 2025-03-31 0001435064 CETX:RichlandIndustriesLLCMember 2026-01-01 2026-03-31 0001435064 CETX:RichlandIndustriesLLCMember 2025-01-01 2025-03-31 0001435064 CETX:RichlandIndustriesLLCMember 2025-10-01 2026-03-31 0001435064 CETX:RichlandIndustriesLLCMember 2024-10-01 2025-03-31 0001435064 2025-02-24 2025-02-24 0001435064 2025-02-23 0001435064 2025-02-24 0001435064 srt:ScenarioPreviouslyReportedMember 2025-01-01 2025-03-31 0001435064 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2025-01-01 2025-03-31 0001435064 srt:ScenarioPreviouslyReportedMember 2024-10-01 2025-03-31 0001435064 srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember 2024-10-01 2025-03-31 0001435064 us-gaap:TransferredOverTimeMember 2026-01-01 2026-03-31 0001435064 us-gaap:TransferredOverTimeMember 2025-01-01 2025-03-31 0001435064 us-gaap:TransferredOverTimeMember 2025-10-01 2026-03-31 0001435064 us-gaap:TransferredOverTimeMember 2024-10-01 2025-03-31 0001435064 us-gaap:TransferredAtPointInTimeMember 2026-01-01 2026-03-31 0001435064 us-gaap:TransferredAtPointInTimeMember 2025-01-01 2025-03-31 0001435064 us-gaap:TransferredAtPointInTimeMember 2025-10-01 2026-03-31 0001435064 us-gaap:TransferredAtPointInTimeMember 2024-10-01 2025-03-31 0001435064 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-03-31 0001435064 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-03-31 0001435064 us-gaap:EmployeeStockOptionMember 2025-10-01 2026-03-31 0001435064 us-gaap:EmployeeStockOptionMember 2024-10-01 2025-03-31 0001435064 us-gaap:WarrantMember 2026-01-01 2026-03-31 0001435064 us-gaap:WarrantMember 2025-01-01 2025-03-31 0001435064 us-gaap:WarrantMember 2025-10-01 2026-03-31 0001435064 us-gaap:WarrantMember 2024-10-01 2025-03-31 0001435064 CETX:SecurityMember 2026-01-01 2026-03-31 0001435064 CETX:IndustrialServicesMember 2026-01-01 2026-03-31 0001435064 CETX:AerospaceAndDefenseMember 2026-01-01 2026-03-31 0001435064 us-gaap:CorporateMember 2026-01-01 2026-03-31 0001435064 CETX:SecurityMember 2025-01-01 2025-03-31 0001435064 CETX:IndustrialServicesMember 2025-01-01 2025-03-31 0001435064 CETX:AerospaceAndDefenseMember 2025-01-01 2025-03-31 0001435064 us-gaap:CorporateMember 2025-01-01 2025-03-31 0001435064 CETX:SecurityMember 2025-10-01 2026-03-31 0001435064 CETX:IndustrialServicesMember 2025-10-01 2026-03-31 0001435064 CETX:AerospaceAndDefenseMember 2025-10-01 2026-03-31 0001435064 us-gaap:CorporateMember 2025-10-01 2026-03-31 0001435064 CETX:SecurityMember 2024-10-01 2025-03-31 0001435064 CETX:IndustrialServicesMember 2024-10-01 2025-03-31 0001435064 CETX:AerospaceAndDefenseMember 2024-10-01 2025-03-31 0001435064 us-gaap:CorporateMember 2024-10-01 2025-03-31 0001435064 CETX:SecurityMember 2026-03-31 0001435064 CETX:SecurityMember 2025-09-30 0001435064 CETX:IndustrialServicesMember 2026-03-31 0001435064 CETX:IndustrialServicesMember 2025-09-30 0001435064 CETX:AerospaceAndDefenseMember 2026-03-31 0001435064 CETX:AerospaceAndDefenseMember 2025-09-30 0001435064 us-gaap:CorporateMember 2026-03-31 0001435064 us-gaap:CorporateMember 2025-09-30 0001435064 CETX:BeneconGroupBondMember 2026-03-31 0001435064 CETX:BeneconGroupBondMember 2025-09-30 0001435064 CETX:HeiseyEscrowBondMember 2026-03-31 0001435064 CETX:HeiseyEscrowBondMember 2025-09-30 0001435064 CETX:BondEscrowMember 2026-03-31 0001435064 CETX:BondEscrowMember 2025-09-30 0001435064 CETX:DepositGuaranteesBondMember 2026-03-31 0001435064 CETX:DepositGuaranteesBondMember 2025-09-30 0001435064 us-gaap:FairValueInputsLevel1Member CETX:DigitalAssetsMember 2026-03-31 0001435064 us-gaap:FairValueInputsLevel2Member CETX:DigitalAssetsMember 2026-03-31 0001435064 us-gaap:FairValueInputsLevel3Member CETX:DigitalAssetsMember 2026-03-31 0001435064 CETX:DigitalAssetsMember 2026-03-31 0001435064 us-gaap:FairValueInputsLevel1Member CETX:MarketableSecuritiesMember 2026-03-31 0001435064 us-gaap:FairValueInputsLevel2Member CETX:MarketableSecuritiesMember 2026-03-31 0001435064 us-gaap:FairValueInputsLevel3Member CETX:MarketableSecuritiesMember 2026-03-31 0001435064 CETX:MarketableSecuritiesMember 2026-03-31 0001435064 us-gaap:FairValueInputsLevel1Member CETX:WarrantLiabilitiesMember 2026-03-31 0001435064 us-gaap:FairValueInputsLevel2Member CETX:WarrantLiabilitiesMember 2026-03-31 0001435064 us-gaap:FairValueInputsLevel3Member CETX:WarrantLiabilitiesMember 2026-03-31 0001435064 CETX:WarrantLiabilitiesMember 2026-03-31 0001435064 us-gaap:FairValueInputsLevel1Member CETX:DigitalAssetsMember 2025-09-30 0001435064 us-gaap:FairValueInputsLevel2Member CETX:DigitalAssetsMember 2025-09-30 0001435064 us-gaap:FairValueInputsLevel3Member CETX:DigitalAssetsMember 2025-09-30 0001435064 CETX:DigitalAssetsMember 2025-09-30 0001435064 us-gaap:FairValueInputsLevel1Member CETX:WarrantLiabilitiesMember 2025-09-30 0001435064 us-gaap:FairValueInputsLevel2Member CETX:WarrantLiabilitiesMember 2025-09-30 0001435064 us-gaap:FairValueInputsLevel3Member CETX:WarrantLiabilitiesMember 2025-09-30 0001435064 CETX:WarrantLiabilitiesMember 2025-09-30 0001435064 2025-07-29 2025-07-29 0001435064 2026-01-07 2026-01-07 0001435064 CETX:SeriesBWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2026-03-31 0001435064 CETX:SeriesBWarrantsMember us-gaap:MeasurementInputExpectedTermMember 2025-09-30 0001435064 CETX:SeriesBWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-03-31 0001435064 CETX:SeriesBWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-09-30 0001435064 CETX:SeriesBWarrantsMember us-gaap:MeasurementInputOptionVolatilityMember 2026-03-31 0001435064 CETX:SeriesBWarrantsMember us-gaap:MeasurementInputOptionVolatilityMember 2025-09-30 0001435064 CETX:SeriesBWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2026-03-31 0001435064 CETX:SeriesBWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember 2025-09-30 0001435064 CETX:SeriesBWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2026-03-31 0001435064 CETX:SeriesBWarrantsMember us-gaap:MeasurementInputExercisePriceMember 2025-09-30 0001435064 CETX:SeriesAWarrantsMember 2025-09-30 0001435064 CETX:SeriesBWarrantsMember 2025-09-30 0001435064 CETX:SeriesAWarrantsMember 2025-10-01 2026-03-31 0001435064 CETX:SeriesBWarrantsMember 2025-10-01 2026-03-31 0001435064 CETX:SeriesAWarrantsMember 2026-03-31 0001435064 CETX:SeriesBWarrantsMember 2026-03-31 0001435064 us-gaap:LandMember 2026-03-31 0001435064 us-gaap:LandMember 2025-09-30 0001435064 us-gaap:BuildingImprovementsMember 2026-03-31 0001435064 us-gaap:BuildingImprovementsMember 2025-09-30 0001435064 us-gaap:FurnitureAndFixturesMember 2026-03-31 0001435064 us-gaap:FurnitureAndFixturesMember 2025-09-30 0001435064 us-gaap:ComputerEquipmentMember 2026-03-31 0001435064 us-gaap:ComputerEquipmentMember 2025-09-30 0001435064 us-gaap:MachineryAndEquipmentMember 2026-03-31 0001435064 us-gaap:MachineryAndEquipmentMember 2025-09-30 0001435064 us-gaap:CostOfRevenue 2026-01-01 2026-03-31 0001435064 us-gaap:GeneralAndAdministrativeExpense 2026-01-01 2026-03-31 0001435064 us-gaap:CostOfRevenue 2025-01-01 2025-03-31 0001435064 us-gaap:GeneralAndAdministrativeExpense 2025-01-01 2025-03-31 0001435064 us-gaap:CostOfRevenue 2025-10-01 2026-03-31 0001435064 us-gaap:GeneralAndAdministrativeExpense 2025-10-01 2026-03-31 0001435064 us-gaap:CostOfRevenue 2024-10-01 2025-03-31 0001435064 us-gaap:GeneralAndAdministrativeExpense 2024-10-01 2025-03-31 0001435064 CETX:SecurityMember 2025-09-30 0001435064 CETX:IndustrialServicesMember 2025-09-30 0001435064 CETX:AerospaceAndDefenseMember 2025-09-30 0001435064 CETX:SecurityMember 2025-10-01 2026-03-31 0001435064 CETX:IndustrialServicesMember 2025-10-01 2026-03-31 0001435064 CETX:AerospaceAndDefenseMember 2025-10-01 2026-03-31 0001435064 CETX:SecurityMember 2026-03-31 0001435064 CETX:IndustrialServicesMember 2026-03-31 0001435064 CETX:AerospaceAndDefenseMember 2026-03-31 0001435064 2020-11-13 0001435064 2022-01-19 0001435064 2023-07-18 0001435064 2023-10-05 0001435064 2024-10-17 0001435064 2024-11-18 0001435064 CETX:SaagarGovilMember 2025-01-06 2025-01-06 0001435064 CETX:SaagarGovilMember CETX:FirstYearMember 2025-01-01 2025-01-01 0001435064 CETX:SaagarGovilMember CETX:SecondYearMember 2026-01-01 2026-01-01 0001435064 CETX:CemtrexXRIncMember 2026-03-31 0001435064 CETX:CXRIncMember 2026-03-31 0001435064 us-gaap:ServiceMember CETX:CemtrexTechnologiesPvtLtdMember 2026-03-31 0001435064 CETX:CemtrexXRIncMember 2025-09-30 0001435064 CETX:TradeReceivablesNetMember 2025-09-30 0001435064 CETX:ContractAssetsNetMember 2025-09-30 0001435064 CETX:RoyaltiesReceivableNetRelatedPartyMember 2025-09-30 0001435064 CETX:TradeReceivablesNetMember 2025-10-01 2026-03-31 0001435064 CETX:ContractAssetsNetMember 2025-10-01 2026-03-31 0001435064 CETX:RoyaltiesReceivableNetRelatedPartyMember 2025-10-01 2026-03-31 0001435064 CETX:TradeReceivablesNetMember 2026-03-31 0001435064 CETX:ContractAssetsNetMember 2026-03-31 0001435064 CETX:RoyaltiesReceivableNetRelatedPartyMember 2026-03-31 0001435064 CETX:ClovisMember 2026-03-31 0001435064 CETX:ClovisMember 2025-10-01 2026-03-31 0001435064 CETX:ClovisMember 2024-10-01 2025-03-31 0001435064 2023-10-05 2023-10-05 0001435064 CETX:StreetervilleCapitalLLCMember 2025-11-07 0001435064 CETX:StreetervilleCapitalLLCMember 2025-12-31 0001435064 2026-01-01 0001435064 CETX:StreetervilleCapitalLLCMember 2025-11-07 2025-11-07 0001435064 CETX:StreetervilleCapitalLLCMember 2026-03-31 0001435064 CETX:RichlandIndustriesLLCMember 2026-03-31 0001435064 CETX:FultonBankMortgagePayableMember 2026-02-05 0001435064 CETX:FultonBankMortgagePayableMember 2026-02-05 2026-02-05 0001435064 CETX:FultonBankMortgagePayableMember 2026-03-31 0001435064 CETX:FultonBankOneMember 2025-10-01 2026-03-31 0001435064 CETX:FultonBankOneMember 2026-03-31 0001435064 CETX:FultonBankOneMember 2025-09-30 0001435064 CETX:FultonBankMortgagePayableMember 2025-10-01 2026-03-31 0001435064 CETX:FultonBankMortgagePayableMember 2026-03-31 0001435064 CETX:FultonBankMortgagePayableMember 2025-09-30 0001435064 CETX:FultonBankHEISEYOneMember 2025-10-01 2026-03-31 0001435064 CETX:FultonBankHEISEYOneMember 2026-03-31 0001435064 CETX:FultonBankHEISEYOneMember 2025-09-30 0001435064 CETX:FultonBankHEISEYTwoMember 2025-10-01 2026-03-31 0001435064 CETX:FultonBankHEISEYTwoMember 2026-03-31 0001435064 CETX:FultonBankHEISEYTwoMember 2025-09-30 0001435064 CETX:FultonBankAISTNMember 2025-10-01 2026-03-31 0001435064 CETX:FultonBankAISTNMember 2026-03-31 0001435064 CETX:FultonBankAISTNOneMember 2025-10-01 2026-03-31 0001435064 CETX:FultonBankAISTNOneMember 2026-03-31 0001435064 CETX:NotesPayableOneMember 2025-10-01 2026-03-31 0001435064 CETX:NotesPayableOneMember 2026-03-31 0001435064 CETX:NotesPayableOneMember 2025-09-30 0001435064 CETX:NotesPayableTwoMember 2025-10-01 2026-03-31 0001435064 CETX:NotesPayableTwoMember 2026-03-31 0001435064 CETX:NotesPayableTwoMember 2025-09-30 0001435064 CETX:NotesPayableThreeMember 2025-10-01 2026-03-31 0001435064 CETX:NotesPayableThreeMember 2026-03-31 0001435064 CETX:NotesPayableThreeMember 2025-09-30 0001435064 CETX:NotesPayableOneMember 2026-03-31 0001435064 CETX:NotesPayableOneMember 2025-10-01 2026-03-31 0001435064 CETX:NotesPayableOneMember 2025-09-30 0001435064 CETX:NotesPayableOneMember 2024-09-30 0001435064 CETX:NotesPayableTwoMember 2026-03-31 0001435064 CETX:NotesPayableTwoMember 2025-10-01 2026-03-31 0001435064 CETX:NotesPayableTwoMember 2025-09-30 0001435064 CETX:NotesPayableThreeMember 2025-10-01 2025-12-31 0001435064 CETX:NotesPayableThreeMember 2026-01-01 0001435064 CETX:SeriesOnePreferredStockMember 2025-10-01 2026-03-31 0001435064 CETX:SeriesAWarrantsMember 2025-10-01 2026-03-31 0001435064 CETX:SeriesAWarrantsMember 2026-03-31 0001435064 CETX:SeriesAWarrantsMember 2026-01-01 2026-03-31 0001435064 us-gaap:CommonStockMember 2025-10-01 2026-03-31 0001435064 CETX:SeriesBWarrantsMember 2026-01-01 2026-03-31 0001435064 CETX:SeriesBWarrantsMember 2025-10-01 2026-03-31 0001435064 CETX:SeriesAWarrantMember 2025-10-13 0001435064 CETX:SeriesBWarrantMember 2025-10-13 0001435064 2025-10-17 0001435064 CETX:SeriesAWarrantMember 2025-12-11 0001435064 CETX:SeriesBWarrantMember 2025-12-11 0001435064 2025-12-11 0001435064 CETX:SeriesAWarrantMember 2025-12-30 0001435064 CETX:SeriesBWarrantMember 2025-12-30 0001435064 2025-12-30 0001435064 CETX:SecuritiesPurchaseAgreementMember 2025-12-11 0001435064 CETX:SecuritiesPurchaseAgreementMember 2025-12-11 2025-12-11 0001435064 CETX:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2025-12-11 2025-12-11 0001435064 CETX:SecuritiesPurchaseAgreementMember us-gaap:WarrantMember 2025-12-11 0001435064 CETX:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2025-12-11 0001435064 CETX:SecuritiesPurchaseAgreementMember 2025-12-23 0001435064 CETX:SecuritiesPurchaseAgreementMember 2025-12-23 2025-12-23 0001435064 CETX:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2025-12-23 2025-12-23 0001435064 CETX:SecuritiesPurchaseAgreementMember us-gaap:WarrantMember 2025-12-23 0001435064 CETX:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2025-12-23 0001435064 CETX:SecuritiesPurchaseAgreementMember 2025-12-30 0001435064 CETX:SecuritiesPurchaseAgreementMember 2025-12-30 2025-12-30 0001435064 CETX:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2025-12-30 2025-12-30 0001435064 CETX:SecuritiesPurchaseAgreementMember us-gaap:WarrantMember 2025-12-30 0001435064 CETX:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2025-12-30 0001435064 CETX:SecuritiesPurchaseAgreementMember 2026-01-09 0001435064 CETX:SecuritiesPurchaseAgreementMember 2026-01-09 2026-01-09 0001435064 CETX:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2026-01-09 2026-01-09 0001435064 CETX:SecuritiesPurchaseAgreementMember us-gaap:WarrantMember 2026-01-09 0001435064 us-gaap:DomesticCountryMember 2025-09-30 0001435064 us-gaap:StateAndLocalJurisdictionMember 2025-09-30 0001435064 us-gaap:ForeignCountryMember 2025-09-30 0001435064 us-gaap:SubsequentEventMember us-gaap:CommonStockMember 2026-04-07 2026-04-07 0001435064 us-gaap:SubsequentEventMember us-gaap:CommonStockMember 2026-04-07 0001435064 us-gaap:SubsequentEventMember 2026-04-07 2026-04-07 0001435064 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2026-04-17 2026-04-17 0001435064 us-gaap:SubsequentEventMember CETX:SeriesBWarrantsMember 2026-04-17 2026-04-17 0001435064 us-gaap:SubsequentEventMember 2026-04-17 2026-04-17 0001435064 us-gaap:SubsequentEventMember us-gaap:CommonStockMember 2026-05-08 2026-05-08 0001435064 us-gaap:SubsequentEventMember 2026-05-08 2026-05-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft CETX:Integer

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934

 

For the quarterly period ended March 31, 2026

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934

 

For the transition period from ___________to ____________

 

Commission File Number 001-37464

 

 

CEMTREX, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   30-0399914
(State or other jurisdiction
of incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

135 Fell Ct. Hauppauge, NY   11788
(Address of principal executive offices)   (Zip Code)

 

631-756-9116

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol   Name of each exchange on which registered
Common Stock   CETX   Nasdaq Capital Market

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

 

Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

  Large accelerated filer ☐ Accelerated filer ☐
  Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

☐ Yes No

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:

 

As of May 13, 2026, the issuer had 11,121,834 shares of common stock issued and outstanding.

 

 

 

 
 

 

CEMTREX, INC. AND SUBSIDIARIES

 

INDEX

 

    Page
     
PART I. FINANCIAL INFORMATION  
     
Item 1. Financial Statements  
     
  Condensed Consolidated Balance Sheets as of March 31, 2026 (Unaudited) and September 30, 2025 3
     
  Condensed Consolidated Statements of Operations for the three and six months ended March 31, 2026 and 2025 (Unaudited) 4
     
  Condensed Consolidated Statements of Comprehensive Loss for the three and six months ended March 31, 2026 and 2025 (Unaudited) 5
     
  Condensed Consolidated Statement of Stockholders’ Equity for the six months ended March 31, 2026 (Unaudited) 6
     
  Condensed Consolidated Statement of Stockholders’ Equity for the six months ended March 31, 2025 (Unaudited) 7
     
  Condensed Consolidated Statements of Cash Flow for the six months ended March 31, 2026 and 2025 (Unaudited) 8
     
  Notes to Unaudited Condensed Consolidated Financial Statements 10
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 33
     
Item 4. Controls and Procedures 38
     
PART II. OTHER INFORMATION  
     
Item 1. Legal Proceedings 39
     
Item 1A Risk Factors 39
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 39
     
Item 3. Defaults Upon Senior Securities 39
     
Item 4. Mine Safety Disclosures 39
     
Item 5. Other Information 39
     
Item 6. Exhibits 40
     
SIGNATURES 41

 

2
 

 

Part I. Financial Information

 

Item 1. Financial Statements

 

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

 

   (Unaudited)     
   March 31,   September 30, 
Assets  2026   2025 
Current assets          
Cash and cash equivalents  $6,567,030   $4,974,303 
Restricted cash   1,343,088    1,372,738 
Marketable securities   5,030,448    - 
Trade receivables, net   13,325,559    13,133,424 
Trade receivables, net - related party   548,554    405,493 
Inventory, net   6,740,579    6,584,944 
Contract assets, net   2,208,569    980,164 
Prepaid expenses and other current assets   2,167,209    1,556,432 
Total current assets   37,931,036    29,007,498 
           
Property and equipment, net   16,540,949    9,651,996 
Right-of-use operating lease assets   2,833,949    2,003,967 
Right-of-use finance lease assets   66,518    - 
Royalties receivable, net - related party   -    190,475 
Digital assets   1,085,163    1,158,238 
Intangible assets, net of amortization     2,981,750       -  
Goodwill   7,686,141    3,708,347 
Other   1,610,868    2,067,755 
Total Assets  $70,736,374   $47,788,276 
           
Liabilities & Stockholders’ Equity          
Current liabilities          
Accounts payable  $4,566,512   $4,492,859 
Sales tax payable   50,887    76,008 
Revolving line of credit   2,035,697    3,176,096 
Current maturities of long-term liabilities   8,770,319    8,925,497 
Operating lease liabilities - short-term   1,249,135    918,391 
Finance lease liabilities - short-term   331,818    - 
Deposits from customers   548,745    158,344 
Accrued expenses   2,555,108    2,223,521 
Accrued payable on inventory in transit   174,076    652,179 
Contract liabilities   2,348,384    1,655,055 
Deferred revenue   1,019,351    1,383,036 
Accrued income taxes   574,433    162,173 
Total current liabilities   24,224,465    23,823,159 
Long-term liabilities          
Long-term debt   8,756,025    4,586,779 
Long-term operating lease liabilities   1,641,599    1,153,221 
Other long-term liabilities   290,000    289,483 
Deferred revenue - long-term   371,551    482,978 
Warrant liabilities   743,499    8,735,197 
Total long-term liabilities   11,802,674    15,247,658 
Total liabilities   36,027,139    39,070,817 
           
Commitments and contingencies   -    - 
           
Stockholders’ equity          
Preferred stock , $0.001 par value, 10,000,000 shares authorized, Series 1, 4,000,000 shares authorized, 2,840,919 shares issued and 2,776,819 shares outstanding as of March 31, 2026 and 2,705,327 shares issued and 2,641,227 shares outstanding as of September 30, 2025 (liquidation value of $10 per share)   2,841    2,705 
Series C, 100,000 shares authorized, 50,000 shares issued and outstanding at March 31, 2026 and September 30, 2025   50    50 
Common stock, $0.001 par value, 70,000,000 shares authorized, 10,078,089 shares issued and outstanding at March 31, 2026 and 830,606 shares issued and outstanding at September 30, 2025   10,078    831 
Additional paid-in capital   151,331,793    105,668,565 
Accumulated deficit   (119,046,840)   (99,397,741)
Treasury stock, 64,100 shares of Series 1 Preferred Stock at March 31, 2026, and September 30, 2025   (148,291)   (148,291)
Accumulated other comprehensive income   2,559,604    2,591,340 
Total stockholders’ equity   34,709,235    8,717,459 
           
Total liabilities and stockholders’ equity  $70,736,374   $47,788,276 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

3
 

 

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

(Unaudited)

 

   March 31, 2026   March 31, 2025   March 31, 2026   March 31, 2025 
   For the three months ended   For the six months ended 
   March 31, 2026   March 31, 2025   March 31, 2026   March 31, 2025 
                 
Revenues  $18,061,367   $27,250,269   $34,194,678   $40,990,168 
Cost of revenues   11,214,163    15,084,814    21,725,608    23,122,777 
Gross profit   6,847,204    12,165,455    12,469,070    17,867,391 
Operating expenses                    
General and administrative   8,472,383    6,770,742    16,398,974    13,864,031 
Research and development   546,858    777,889    1,048,293    1,667,972 
Total operating expenses   9,019,241    7,548,631    17,447,267    15,532,003 
Operating (loss)/income   (2,172,037)   4,616,824    (4,978,197)   2,335,388 
Other income/(expense)                    
Other income/(expense), net   6,047    (150,165)   41,302    (115,192)
Interest expense   (562,383)   (452,998)   (12,686,078)   (936,911)
Changes in fair value of digital assets   (628,581)   -    (1,098,441)   - 
Bargain purchase gain   2,068,047    -    2,068,047    - 
Gain/(loss) on exercise of warrant liabilities   16,224    -    (4,658,582)   (15,796,105)
Changes in fair value of warrant liability   2,568,357    4,707,374    2,285,811    (5,312,838)
Total other income/(expense), net   3,467,711    4,104,211    (14,047,941)   (22,161,046)
Net income/(loss) before income taxes   1,295,674    8,721,035    (19,026,138)   (19,825,658)
Income tax expense   73,859    110,525    340,185    231,063 
Income/(loss) from continuing operations   1,221,815    8,610,510    (19,366,323)   (20,056,721)
(Loss)/income from discontinued operations, net of tax   (314,767)   26,969    (282,776)   (240,319)
Net income/(loss)   907,048    8,637,479    (19,649,099)   (20,297,040)
Less net income in noncontrolling interest   -    -    -    (180,152)
Net income/(loss) attributable to Cemtrex, Inc. stockholders  $907,048   $8,637,479   $(19,649,099)  $(20,116,888)
Income/(loss) per share - Basic                    
Continuing Operations  $0.12   $72.19   $(3.11)  $(215.24)
Discontinued Operations  $(0.03)  $0.23   $(0.05)  $(2.60)
Income/(loss) per share - Diluted                                
Continuing Operations   $ 0.11     $ 19.51     $ (2.97 )   $ (48.11 )
Discontinued Operations   $ (0.03 )   $ 0.06     $ (0.04 )   $ (0.58 )
Weighted Average Number of Shares-Basic   9,946,752    118,972    6,247,421    92,450 
Weighted Average Number of Shares-Diluted     10,237,983       440,146       6,538,652       413,624  

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

4
 

 

Condensed Consolidated Statements of Comprehensive Income/(Loss)

(Unaudited)

 

   March 31, 2026   March 31, 2025   March 31, 2026   March 31, 2025 
   For the three months ended   For the six months ended 
   March 31, 2026   March 31, 2025   March 31, 2026   March 31, 2025 
Other comprehensive loss                    
Net income/(loss)  $907,048   $8,637,479   $(19,649,099)  $(20,297,040)
Foreign currency translation gain/(loss)   687,749    (423,482)   (31,736)   (554,921)
Comprehensive income/(loss)   1,594,797    8,213,997    (19,680,835)   (20,851,961)
Less net loss in noncontrolling interest   -    -    -    (180,152)
Comprehensive income/(loss) attributable to Cemtrex, Inc. stockholders  $1,594,797   $8,213,997   $(19,680,835)  $(20,671,809)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

5
 

 

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statement of Stockholders’ Equity

(Unaudited)

 

  

Number of

Shares

   Amount  

Number of

Shares

   Amount  

Number of

Shares

   Amount  

Paid-in

Capital

  

Accumulated

Deficit

   Preferred Stock  

Comprehensive

Income

  

Stockholders’

Equity

 
  

Preferred Stock Series 1

Par Value $0.001

  

Preferred Stock Series C

Par Value $0.001

  

Common Stock
Par Value $0.001

   Additional       Treasury Stock, 64,100 shares of Series 1   Accumulated
other
   Cemtrex 
  

Number of

Shares

   Amount  

Number of

Shares

   Amount  

Number of

Shares

   Amount  

Paid-in

Capital

  

Accumulated

Deficit

   Preferred Stock  

Comprehensive

Income

  

Stockholders’

Equity

 
Balance at September 30, 2025   2,705,327   $2,705         50,000   $50    830,606   $831   $105,668,565   $(99,397,741)  $(148,291)  $2,591,340   $    8,717,459 
Foreign currency translation loss                                                (719,485)   (719,485)
Dividends paid in Series 1 preferred shares   135,592    136                        (136)                  - 
Shares issued to pay debt                       3,000,296    3,001    19,639,282                   19,642,283 
Exercise of Series A warrants                       29,943    30    211,068                   211,098 
Exercise of Series B warrants                       2,316,480    2,317    15,802,537                   15,804,854 
Shares issued in offering                       2,355,556    2,356    5,988,171                   5,990,527 
Issuance of roundup shares                       67,671    66    (66)                  - 
Net loss                  -                    (20,556,147)   -          (20,556,147)
Balance at December 31, 2025   2,840,919   $2,841    50,000   $50    8,600,552   $8,601   $147,309,421   $(119,953,888)  $(148,291)  $1,871,855   $29,090,589 
Foreign currency translation gain                                                687,749    687,749 
Exercise of Series B warrants                       8,030    8    23,841                   23,849 
Shares issued in offering                       1,469,507    1,469    3,998,531                   4,000,000 
Net income        -          -                    907,048    -          907,048 
Balance at March 31, 2026   2,840,919   $2,841    50,000   $50    10,078,089   $10,078   $151,331,793   $(119,046,840)  $(148,291)  $2,559,604   $34,709,235 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

6
 

 

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statement of Stockholders’ Equity (Continued)

(Unaudited)

 

   Number of Shares   Amount   Number of Shares   Amount   Number of Shares   Amount   Paid-in
Capital
   Accumulated
Deficit
   Series 1 Preferred Stock   Comprehensive
Income
   Stockholders’
Equity
   controlling
interest
 
   Preferred Stock Series 1
Par Value $0.001
   Preferred Stock Series C
Par Value $0.001
  

Common Stock

Par Value $0.001

   Additional       Treasury Stock, 64,100 shares of    Accumulated
other
   Cemtrex   Non- 
   Number of Shares   Amount   Number of Shares   Amount   Number of Shares   Amount   Paid-in
Capital
   Accumulated
Deficit
   Series 1 Preferred Stock   Comprehensive
Income
   Stockholders’
Equity
   controlling
interest
 
Balance at September 30, 2024   2,456,827   $2,457       50,000   $50              946   $1   $73,262,549   $(71,355,386)  $(148,291)  $2,949,297   $    4,710,677   $250,165 
Foreign currency translation loss                                                (131,439)   (131,439)     
Share-based compensation                                 4,087                   4,087      
Dividends paid in Series 1 preferred shares   123,167    123                        (123)                  -      
Exercise of Series A warrants                       88,492    89    21,515,688                   21,515,777      
Exercise of Series B warrants                       22,244    22    1,095,709                   1,095,731      
Issuance of roundup shares                       7,299    7    (7)                  -      
Loss attributable to noncontrolling interest                                                     -    (180,152)
Net loss                  -                    (28,754,367)   -          (28,754,367)     
Balance at December 31, 2024   2,579,994   $2,580    50,000   $50    118,981   $119   $95,877,903   $(100,109,753)  $(148,291)  $2,817,858   $(1,559,534)  $70,013 
Foreign currency translation loss                                                (423,482)   (423,482)     
Share-based compensation                                 3,096                   3,096      
Rounding shares                       1                             -      
Elimination of non-controlling interest                                      70,013              70,013    (70,013)
Net income        -          -                    8,637,479    -          8,637,479      
Balance at March 31, 2025   2,579,994    2,580    50,000    50    118,982    119    95,880,999    (91,402,261)   (148,291)   2,394,376    6,727,572    - 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

7
 

 

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

Cash Flows from Operating Activities  2026   2025 
   For the six months ended
March 31,
 
Cash Flows from Operating Activities  2026   2025 
         
Net loss   (19,649,099)   (20,297,040)
           
Adjustments to reconcile net loss to net cash used by operating activities          
Depreciation and amortization   1,015,907    648,025 
(Gain)/loss on disposal of property and equipment   (1,007)   19,668 
Noncash lease expense   580,751    461,490 
Interest on finance leases   496    - 
Loss on marketable securities   69,552    - 
Credit loss (recovery)/expense   (2,409)   10,572 
Loss on write-off of related party receivables   215,779    - 
Contract modification - related party   -    280,545 
Share-based compensation   -    7,183 
Bargain purchase gain   (2,068,047)   - 
Write-off of demonstration equipment   441,624    - 
Interest expense paid in equity shares   11,798,283    - 
Accrued interest on notes payable   

341,982

    530,404 
Non-cash royalty income   (243,525)   (71,464)
Amortization of original issue discounts on notes payable   221,875    16,667 
Loan origination costs   25,000    5,000 
Receipt of SOL from staking   (31,683)   - 
Non-cash transaction fees   6,884    - 
Unrealized loss on digital assets   1,098,441    - 
Loss on exercise of warrant liabilities   4,658,582    15,796,105 
Changes in fair value of warrant liability   (2,285,811)   5,312,838 
           
Changes in operating assets and liabilities net of effects from acquisition of subsidiaries:          
Trade receivables   1,014,607    (1,536,888)
Trade receivables - related party   35,160    66,057 
Inventory   142,207    851,764 
Contract assets   (566,550)   (171,413)
Prepaid expenses and other current assets   (492,520)   (569,401)
Other assets   15,263    173,497 
Accounts payable   (696,851)   (518,330)
Sales tax payable   (25,121)   (69,054)
Operating lease liabilities   (582,108)   (464,886)
Deposits from customers   140,401    (225,560)
Accrued expenses   (586,966)   972,123 
Contract liabilities   160,792    670,221 
Deferred revenue   (475,112)   (266,217)
Income taxes payable   412,260    (38,617)
Other liabilities   517    7,243 
Net cash (used in)/provided by operating activities   (5,310,446)   1,600,532 
           
Cash Flows from Investing Activities          
Purchase of property and equipment   (336,782)   (1,359,963)
Proceeds from sale of property and equipment   19,592    13,511 
Royalties on related party revenues   40,000    10,000 
Purchase of marketable securities   (5,100,000)   - 
Acquisitions, net of cash acquired   (7,594,695)   - 
Investment in digital assets   (1,000,567)   - 
Investment in MasterpieceVR   -    (100,000)
Net cash used by investing activities   (13,972,452)   (1,436,452)
           
Cash Flows from Financing Activities          
Proceeds on revolving line of credit   10,511,864    18,925,223 
Payments on revolving line of credit   (12,048,307)   (19,182,809)
Payments on debt   (250,767)   (240,510)
Finance lease liabilities   (6,897)     
Payments on Paycheck Protection Program Loans   -    (20,247)
Proceeds from notes payable   7,000,000    500,000 
Proceeds from warrant exercises   5,675,332    1,050,597 
Proceeds from offerings   10,000,000    - 
Expenses on offerings   (9,473)   - 
Net cash provided by financing activities   

20,871,752

    1,032,254 
           
Effect of currency translation   (25,777)   (550,693)
Net increase in cash, cash equivalents, and restricted cash   1,588,854    1,196,334 
Cash, cash equivalents, and restricted cash at beginning of period   6,347,041    5,420,392 
Cash, cash equivalents, and restricted cash at end of period  $7,910,118   $6,066,033 

 

Balance Sheet Accounts Included in Cash, Cash Equivalents, and Restricted Cash  March 31, 2026   March 31, 2025 
Cash and cash equivalents  $6,567,030   $4,538,405 
Restricted cash   1,343,088    1,527,628 
Total cash, cash equivalents, and restricted cash  $7,910,118   $6,066,033 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

8
 

 

Cemtrex, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows (Continued)

(Unaudited)

 

Supplemental Disclosure of Cash Flow Information:  2026   2025 
   For the six months ended 
   March 31, 
Supplemental Disclosure of Cash Flow Information:  2026   2025 
Cash paid during the period for interest  $323,938   $389,840 
Cash paid during the period for income taxes, net of refunds  $107,621   $269,680 
           
Supplemental Schedule of Non-Cash Investing and Financing Activities          
Shares issued to pay notes payable  $19,642,283   $- 
Noncash dividends  $136   $123 
Financing of Building Purchase  $3,920,000   $- 
Financing of Acquisitions  $600,000   $- 
Noncash recognition of new leases  $750,580   $204,726 
Series A Warrant Exercises  $211,098   $21,515,777 
Series B Warrant Exercises  $15,828,703   $- 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

9
 

 

Cemtrex, Inc. and Subsidiaries

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 1 – ORGANIZATION AND PLAN OF OPERATIONS

 

Cemtrex was incorporated in 1998 in the state of Delaware and has evolved through strategic acquisitions and internal growth into a leading multi-industry company. Unless the context requires otherwise, all references to “we”, “our”, “us”, “Company”, “registrant”, “Cemtrex” or “management” refer to Cemtrex, Inc. and its subsidiaries.

 

The Company’s reporting segments consist of Security, Industrial Services, and Aerospace and Defense. Additionally, the Company’s operational structure also reports unallocated corporate expenses.

 

Security

 

Cemtrex’s Security segment operates under the brand of its subsidiary, Vicon Industries, Inc. (“Vicon”), which provides end-to-end security solutions to meet the toughest corporate, industrial, and governmental security challenges. Vicon’s products include browser-based video monitoring systems and analytics-based recognition systems, cameras, servers, and access control systems for every aspect of security and surveillance in industrial and commercial facilities, federal prisons, hospitals, universities, schools, and federal and state government offices. Vicon provides innovative, mission critical security and video surveillance solutions utilizing Artificial Intelligence (AI) based data algorithms.

 

Industrial Services

 

Cemtrex’s Industrial Services segment operates under the brand, Advanced Industrial Services (“AIS”), which offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. AIS installs high precision equipment in a wide variety of industrial markets like automotive, printing & graphics, industrial automation, packaging, and chemicals, among others. AIS is a leading provider of reliability-driven maintenance and contracting solutions for machinery, packaging, printing, chemical, and other manufacturing markets. We help customers seeking to achieve greater plant and asset utilization and efficiency by cutting costs and increasing production from existing assets, including small projects to major capital investments, turnarounds, maintenance, specialty welding services, and high-quality scaffolding and platforms.

 

Aerospace and Defense

 

Cemtrex’s Aerospace and Defense segment operates under the brand Invocon, Inc., which offers designing, manufacturing, and supporting advanced instrumentation, wireless sensing, and telemetry systems deployed across satellites, launch vehicles, target missiles, and space-based platforms. Its technologies support numerous government and prime contractor programs, including multiple Space Shuttle and International Space Station systems, and the company maintains long-standing relationships across the Missile Defense Agency and leading aerospace and defense primes.

 

Common Stock Reverse Stock Split

 

On October 2, 2024, November 26, 2024, and September 29, 2025, the Company completed 60:1, 35:1, and 15:1 respectively, reverse stock split on its common stock. All share and per share data have been retroactively adjusted for the reverse splits.

 

Acquisitions

 

The Company accounts for business combinations are using the acquisition method. The consideration transferred is measured at fair value, which is calculated as the sum of the acquisition-date fair values of the assets transferred, liabilities incurred, and equity interests issued. Acquisition-related costs are expensed as incurred. Identifiable assets acquired and liabilities assumed are measured at their acquisition-date fair values.

 

On January 8, 2026, the Company completed the acquisition of Invocon, Inc. (“Invocon”). As a result of the transaction, Invocon became a wholly owned subsidiary of the Company. The purchase price of $7,060,000 was paid in cash at closing. Invocon will be the launch of the Company’s Aerospace and Defense segment with reporting results beginning in the second quarter of fiscal year 2026. This acquisition is part of the Company’s strategy to grow through strategic acquisitions in stable market sectors.

 

10
 

 

The purchase price allocation presented below is still preliminary but has been developed based on an estimate of fair values of Invocon’s identifiable tangible and intangible assets acquired and liabilities assumed as of January 8, 2026. The final allocation of the purchase price will be determined within one year from the closing date of the Invocon acquisition.

 

The acquisition of Invocon was accounted for as a business combination under ASC 805 using the acquisition method of accounting. The assets and liabilities acquired, affected for adjustments to reflect fair values assigned to assets purchased and liabilities assumed, and results of operations, are included in the Company’s condensed consolidated financial statements from the Invocon acquisition date.

 

The Company determined that developed technology was the primary intangible acquired. Under ASC 820-10-55-3A, fair value should reflect market participant assumptions and the asset’s ability to generate cash flows, supporting an income approach and also states the Multi-Period Excess Earnings Method (“MPEEM”) is typically applied when the subject intangible asset is the primary driver of earnings. Because the developed technology is the primary driver of earnings, the MPEEM appropriately isolates its economic contribution after deducting contributory asset charges. Significant assumptions utilized included projected cash flows, royalty rates, risk free rate commensurate with the period to determine the value of developed software and tradenames.

 

The consideration transferred and preliminary allocation of Invocon’s tangible and intangible assets and liabilities, are as follows:

 

   Preliminary 
Consideration Transferred:     
Cash  $7,060,000 
Less cash acquired   (389,193)
Total consideration transferred  $6,670,807 
      
Purchase Price Allocation:     
Accounts receivable   98,981 
Prepaid expenses   71,661 
Contract assets   127,465 
Property and equipment   779 
Right-of-use assets   650,650 
Intangible assets     3,130,000  
Accounts payable   (158,056)
Accrued expenses   (338,531)
Contract liabilities   (239,286)
Lease liabilities   (650,650)
Goodwill   3,977,794 
Total consideration transferred  $6,670,807 

 

The pro forma summary below presents the results of operations as if the Invocon acquisition occurred on October 1, 2024. Proforma adjustments for the three and six months ended March 31, 2026, includes $(2,214), and $393,750 respectively, of interest expense from the Company’s $7,025,000 note payable used to fund the transaction, income tax benefit of $2,663, and $148,251 of amortization on recognized intangible assets for the three months ended March 31, 2026, and six months ended March 31, 2026. Proforma adjustments for the three and six months ended March 31, 2025, includes $165,475, and $(393,750), respectively, of interest expense from the Company’s $7,025,000 note payable used to fund the transaction, $25,000 of legal fees related to the acquisition, $148,251 of amortization on recognized intangible assets and income tax expense of $727 for the three months ended March 31, 2025, $321,502 of amortization on recognized intangible assets and $171,604 of income tax expense for the six months ended March 31, 2025. The pro forma summary uses estimates and assumptions based on information available at the time. Management believes the estimates and assumptions to be reasonable; however, actual results may have differed significantly from this proforma financial information. The pro forma information does not reflect any cost savings, operating synergies or revenue enhancements that might have been achieved from combining the operations. The unaudited pro forma summary is provided for illustrative purposes only and does not purport to represent the Company’s actual consolidated results of operations had the acquisition been completed as of the date presented, nor should it be considered indicative of Cemtrex’s future consolidated results of operations.

 

   Unaudited   Unaudited   Unaudited   Unaudited 
   For the three
months ended
   For the three
months ended
   For the six
months ended
   For the six
months ended
 
   March 31, 2026   March 31, 2025   March 31, 2026   March 31, 2025 
                 
Revenues  $18,865,872   $28,309,447   $34,999,183   $42,943,216 
Net income/(loss)  $408,543  

$

8,226,096   $(20,543,568)  $(21,150,249)

 

On February 5, 2026, the Company, through its subsidiary AIS, acquired substantially all the assets of Richland Industries LLC (“Richland”), an industrial services and fabrication company located in Tennessee. In connection with the transaction, AIS established a new subsidiary, AIS Tennessee, Inc (“AIS – TN”), as part of the Company’s Industrial Services Segment. The acquisition was made to bring in vital services that AIS had previously outsourced. The purchase price of $600,000 was paid via a note payable issued by Fulton Bank. This note carries interest of 6.09% and matures on February 1, 2031. In addition, the Company purchased Richland’s primary facility for $4,900,000 via a $3,920,000 mortgage issued by Fulton Bank and the balance including taxes, closing costs, and fees in cash. This mortgage has carries interest of SOFR plus 2.75% and matures on February 1, 2041.

 

11
 

 

The acquisition of Richland was accounted for as a business combination under ASC 805 using the acquisition method of accounting. The assets and liabilities acquired, affected for adjustments to reflect fair values assigned to assets purchased and liabilities assumed, and results of operations, are included in the Company’s condensed consolidated financial statements from the Richland acquisition date.

 

The purchase price allocation presented below is still preliminary but has been developed based on an estimate of fair values of Richland identifiable tangible and intangible assets acquired and liabilities assumed as of February 5, 2026. The final allocation of the purchase price will be determined within one year from the closing date of the Richland acquisition.

 

The consideration transferred and preliminary allocation of AIS - TN tangible and intangible assets and liabilities, are as follows:

 

   Preliminary 
Consideration Transferred:     
Cash  $1,176,593 
Note payable to finance acquisition   4,520,000 
Less cash acquired   (252,705)
Total consideration transferred  $5,443,888 
      
Purchase Price Allocation:     
Accounts receivable   1,105,352 
Prepaid expenses   46,596 
Inventory   308,247 
Contract assets   534,390 
Property and equipment   7,443,593 
Right-of-use assets   76,021 
Other assets   4,188 
Accounts payable   (606,439)
Letter of credit   (396,022)
Accrued expenses   (122,522)
Contract liabilities   (293,251)
Lease liabilities   (338,218)
Long-term debt   (250,000)
Bargain purchase gain   (2,068,047)
Total consideration transferred  $5,443,888 

 

The pro forma summary below presents the results of operations as if the Richland acquisition occurred on October 1, 2024. Proforma adjustments for the three and six months ended March 31, 2026, includes $10,008, and $13,976, respectively, of interest expense from the Company’s 600,000 note payable used to fund the transaction, and income tax benefit of $22,537 for the three months ended March 31, 2026, and $114,432 of income tax benefit for the six months ended March 31, 2026. Proforma adjustments for the three and six months ended March 31, 2025, includes $9,347, and $18,564, respectively, of interest expense from the Company’s 600,000 note payable used to fund the transaction, and income tax benefit of $37,364 for the three months ended March 31, 2025, and $63,230 of income tax expense for the six months ended March 31, 2025. The pro forma summary uses estimates and assumptions based on information available at the time. Management believes the estimates and assumptions to be reasonable; however, actual results may have differed significantly from this proforma financial information. The pro forma information does not reflect any cost savings, operating synergies or revenue enhancements that might have been achieved from combining the operations. The unaudited pro forma summary is provided for illustrative purposes only and does not purport to represent the Company’s actual consolidated results of operations had the acquisition been completed as of the date presented, nor should it be considered indicative of Cemtrex’s future consolidated results of operations.

 

   Unaudited   Unaudited   Unaudited   Unaudited 
   For the three
months ended
   For the three
months ended
   For the six
months ended
   For the six
months ended
 
   March 31, 2026   March 31, 2025   March 31, 2026   March 31, 2025 
                 
Revenues  $18,511,558   $30,403,614   $37,031,105   $47,451,363 
Net(loss)/income  $380,868  $8,316,781   $(20,517,585)  $(21,716,395)

 

Going Concern Considerations

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared assuming the Company will continue as a going concern and in accordance with generally accepted accounting principles in the United States of America. The going concern basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. Pursuant to the requirements of the ASC 205, management must evaluate whether there are conditions or events, considered in the aggregate, which raise substantial doubt about the Company’s ability to continue as a going concern for one year from the date these financial statements are issued.

 

12
 

 

This evaluation does not take into consideration the potential mitigating effect of management’s plans that have not been fully implemented or are not within control of the Company as of the date the financial statements are issued. When substantial doubt exists under this methodology, management evaluates whether the mitigating effect of its plans sufficiently alleviates substantial doubt about the Company’s ability to continue as a going concern. The mitigating effect of management’s plans, however, is only considered if both (1) it is probable that the plans will be effectively implemented within one year after the date that the financial statements are issued, and (2) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued.

 

The Company has incurred substantial net losses attributable to Cemtrex, Inc. stockholders of $28,112,368 and $7,229,491 for fiscal years 2025 and 2024, respectively and a net losses attributable to Cemtrex, Inc. stockholders of $19,649,099 for the six months ended March 31, 2026, and has debt obligations over the next fiscal year of $10,806,016 that raise substantial doubt with respect to the Company’s ability to continue as a going concern.

 

While the Company’s losses and current debt indicate a substantial doubt regarding the Company’s ability to continue as a going concern, the Company has historically, from time to time, satisfied and may continue to satisfy certain short-term liabilities through the issuance of common stock, thus reducing our cash requirement to meet our operating needs. These transactions add additional significant non-operational expenses which are non-cash in nature. The Company has $7,910,118 in cash and cash equivalents and restricted cash as of March 31, 2026. Additionally, the Company has (i) secured a line of credit for its Vicon brand to fund operations, which as of March 31, 2026, has available capacity of approximately $1,100,000, (ii) continually reevaluate our pricing model on the Company’s Vicon brand to improve margins on those products, (iii) raised $5,675,332 through the exercise of our Series B warrants during the six months ended March 31, 2026 (iv) raised $10,000,000 in gross proceeds in equity offering during the six months ended March 31, 2026 (v) Invested approximately $5,000,000 of the Company’s surplus cash in various marketable securities to generate income on those investments. In the event additional capital is raised through equity offerings and/or debt is satisfied with equity, it may have a dilutive effect on our existing stockholders. While the Company believes these plans, if successful, would be sufficient to meet the capital demands of the Company’s current operations for at least the next twelve months, there is no guarantee that the Company will succeed.

 

Overall, there is no guarantee that cash flow from our existing or future operations and any external capital that we may be able to raise will be sufficient to meet our working capital needs. The Company currently does not have adequate cash or available liquidity/available capacity on our lines of credit to meet our long-term needs and our above plans in the short term may prove to be inadequate to continue as a going concern. Thus, despite our cash on hand, our ability to draw on our credit line, or changes to our pricing models, and other safeguards, we may be unable to meet our obligations as they become due over the next twelve months beyond the issuance date. The unaudited condensed consolidated financial statements do not include any adjustments relating to this uncertainty.

 

NOTE 2 – INTERIM STATEMENT PRESENTATION

 

Basis of Presentation and Use of Estimates

 

The accompanying unaudited condensed consolidated financial information should be read in conjunction with the audited consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended September 30, 2025.

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the Unites States (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X pursuant to the requirements of the U.S. Securities and Exchange Commission (‘SEC”). Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. The results of operations for the interim periods are not necessarily indicative of the results of operations for the entire year.

 

13
 

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the condensed consolidated financial statements, the disclosure of contingent assets and liabilities in the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenues, expenses and cash flows during the periods presented. Actual amounts and results could differ from those estimates. The estimates and assumptions the Company makes are based on historical factors, current circumstances and the experience and judgment of the Company’s management. The Company evaluates its estimates and assumptions on an ongoing basis.

 

Significant Accounting Policies

 

Note 2 of the Notes to Consolidated Financial Statements, included in the annual report on Form 10-K for the year ended September 30, 2025, includes a summary of the significant accounting policies used in the preparation of the unaudited condensed consolidated financial statements.

 

Recently Adopted Accounting Pronouncements

 

In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which requires public entities to disclose consistent categories and greater disaggregation of information in the rate reconciliation and for income taxes paid. It also includes certain other amendments to improve the effectiveness of income tax disclosures. The guidance is effective for financial statements issued for annual periods beginning after December 15, 2024, with early adoption permitted. The Company adopted this standard on October 1, 2025. The Company does not believe that this will have a material effect on the unaudited condensed consolidated financial statements.

 

Recently Issued Accounting Pronouncements Not Yet Effective

 

In October 2023, the FASB issued ASU 2023-06, Disclosure Improvements: Codification Amendments in Response to the SEC’s Disclosure Update and Simplification Initiative, to amend certain disclosure and presentation requirements for a variety of topics within the Accounting Standards Codification (“ASC”). These amendments align the requirements in the ASC to the removal of certain disclosure requirements set out in Regulation S-X and Regulation S-K, announced by the SEC. The effective date for each amended topic in the ASC is the date on which the SEC’s removal of the related disclosure requirement from Regulation S-X or Regulation S-K becomes effective. Early adoption is prohibited. The Company does not anticipate that the ASU will have a material effect on the Company’s unaudited financial statements and related disclosures.

 

In November 2024, the FASB issued ASU 2024-03, “Income Statement (Topic 220): Reporting Comprehensive Income - Expense Disaggregation Disclosures, Disaggregation of Income Statement Expenses”, that requires public companies to disclose, in interim and reporting periods, additional information about certain expenses in the financial statements. ASU 2024-03 is effective for annual periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted and is effective on either a prospective basis or retrospective basis. The Company is currently assessing the potential impacts of adoption on the unaudited condensed consolidated financial statements.

 

In November 2024, the FASB issued ASU 2024-04, “Debt with Conversion and Other Options (Subtopic 470-20), which clarifies the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. ASU 2024-04 is effective for annual periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Early adoption is permitted for all entities that have adopted the amendments in Update 2020-06. Adoption can be on a prospective or retrospective basis. The Company is currently in the process of evaluating the impact of adoption on the unaudited condensed consolidated financial statements.

 

In July 2025, the FASB issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326). This guidance contains amendments that provide decision-useful information to investors and other financial statement users while reducing the time and effort necessary to analyze and estimate credit losses for current accounts receivable and current contract assets. The amendments will be effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Early adoption is permitted in both interim and annual reporting periods in which financial statements have not yet been issued or made available for issuance. The Company is currently evaluating the impact of ASU 2025-05 on its unaudited condensed consolidated financial statements and related disclosures.

 

14
 

 

In December 2025, the FASB issued ASU 2025-11 - Interim Reporting (“ASU 2025-11”) which is intended to improve the navigability of the guidance in ASC 270, Interim Reporting, and clarify when it applies. Under the amendments, an entity is subject to ASC 270 if it provides interim financial statements and notes in accordance with GAAP. ASU 2025-11 also addresses the form and content of such financial statements, interim disclosures requirements, and establishes a principle under which an entity must disclose events since the end of the last annual reporting period that have a material impact on the entity. ASU 2025-11 is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027, and early adoption is permitted. The Company is currently evaluating the impact the adoption of ASU 2025-11 may have on the Company’s unaudited consolidated financial statements.

 

In April 2026, the FASB issued Accounting Standards Update No. 2026-01, Equity (Topic 505): Initial Measurement of Paid-in-Kind Dividends on Equity-Classified Preferred Stock. The amendments in this Update clarify that PIK dividends on equity-classified preferred stock should be initially measured at the amount specified in the agreement, generally calculated by multiplying the PIK dividend rate by the liquidation value of the preferred stock outstanding. The standard is effective for the Company for fiscal years beginning after December 15, 2026. The Company is currently evaluating the impact the adoption of ASU 2026-01 may have on the Company’s unaudited consolidated financial statements.

 

The Company does not believe that any other recently issued but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying unaudited condensed consolidated financial statements.

 

Correction of an Immaterial Error in Previously Issued Financial Statements

 

Subsequent to the issuance of our financial statements for the quarter ended March 31, 2026, an immaterial error was identified and has been corrected in our historical information related to the net income/(loss) in noncontrolling interest. On February 24, 2025, the Company filed a Certificate of Amendment to the Certificate of Incorporation for Vicon Industries Inc. This amendment effected a reverse stock split which exchanged 98,521 for 6 shares of common stock and reduces the number of authorized common shares from 75,000,000 to 15,000.

 

The effects of the correction to the individual effected line items in our Consolidated Statement of Operations are as follows:

 

   As previously reported   Corrections   As corrected 
   For the three months ended March 31, 2025 
   As previously reported   Corrections   As corrected 
             
Less net income/(loss) in noncontrolling interest   254,537    (254,537)   - 
Net income/(loss) attributable to Cemtrex, Inc. stockholders  $8,382,942   $254,537   $8,637,479 

 

   As previously reported   Corrections   As corrected 
   For the six months ended March 31, 2025 
   As previously reported   Corrections   As corrected 
             
Less net income/(loss) in noncontrolling interest   74,385    (254,537)   (180,152)
Net income/(loss) attributable to Cemtrex, Inc. stockholders  $(20,371,425)  $254,537   $(20,116,888)

 

15
 

 

NOTE 3 – REVENUE

 

The following table illustrates the approximate disaggregation of the Company’s revenue based off timing of revenue recognition for the three and six months ended March 31, 2026, and 2025:

 

   March 31, 2026   March 31, 2025   March 31, 2026   March 31, 2025 
   For the three months ended   For the six months ended 
   March 31, 2026   March 31, 2025   March 31, 2026   March 31, 2025 
Over time   71%   40%   71%   49%
Point-in-time   29%   60%   29%   51%

 

NOTE 4 – INCOME/(LOSS) PER COMMON SHARE

 

Basic net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net income by the weighted average number of shares of common stock and potentially dilutive outstanding shares of common stock during the period to reflect the potential dilution that could occur from common shares issuable through contingent share arrangements, stock options, and warrants. For the three and six months ended March 31, 2026, and 2025, the following items were excluded from the computation of diluted net loss per common share as their effect is anti-dilutive:

 

   March 31, 2026   March 31, 2025   March 31, 2026   March 31, 2025 
   For the three months ended   For the six months ended 
   March 31, 2026   March 31, 2025   March 31, 2026   March 31, 2025 
                 
Options   7    7    7    7 
Warrants   1,068,339    3,318,556    1,068,339    3,318,556 

 

For the three and six months ended March 31, 2026, and 2025, loss per share basic and diluted for continuing operations are calculated as follows:

 

   2026   2025   2026   2025 
   For the three months ended   For the six months ended 
   March 31,   March 31, 
   2026   2025   2026   2025 
Net income/(loss)  $907,048   $8,637,479   $(19,649,099)  $(20,297,040)
Less(loss)/income from discontinued operations, net of tax   (314,767)   26,969    (282,776)   (240,319)
Less net loss in noncontrolling interest   -    -    -    (180,152)
Preferred stock dividends   46,918    21,949    46,918    21,949 
Net income/(loss) applicable to common shareholders   1,174,983    8,588,561    (19,413,241)   (19,898,158)

Weighted Average Number of Shares-Basic

   9,946,752    118,972    6,247,421    92,450 

Weighted Average Number of Shares-Diluted

   10,237,983    440,146    6,538,652    413,624 

Loss per share - Basic - Continuing Operations

  $0.12   $72.19   $(3.11)  $(215.24)

Loss per share - Diluted - Continuing Operations

  $0.11   $19.51   $(2.97)  $(48.11)
Loss per share - Basic - Discontinued Operations  $

(0.03

)  $0.23   $(0.05)  $(2.60)
Loss per share - Diluted - Discontinued Operations  $

(0.03

)  $

0.06

   $

(0.04

)  $

(0.58

)

 

In accordance with ASC 260-45-13, the common shares underlying the Series A Warrants under the alternative cashless exercise have been included in the calculation of the weighted average shares.

 

NOTE 5 – SEGMENT INFORMATION

 

The Company reports and evaluates financial information for three reportable segments: the Security segment, Industrial Services segment, and the Aerospace and Defense segment. The Chief Operating Decision Maker (“CODM”) for all segments is Saagar Govil, the CEO of the Company.

 

Unallocated corporate expenses mainly relate to payroll and benefits for corporate officers, investor relation expenses, accounting expenses related to audit and taxes, legal expenses related to corporate matters, interest expense on notes payable, and Series A and B Warrants transaction losses.

 

16
 

 

The following tables summarize the Company’s reportable segment information and unallocated corporate expenses:

 

   Security   Industrial Services   Aerospace and Defense   Corporate   Consolidated 
   Three months ended March 31, 2026 
   Reportable Segments         
   Security   Industrial Services   Aerospace and Defense   Corporate   Consolidated 
External revenues  $5,776,557   $11,038,046   $1,232,592   $14,172   $18,061,367 
Cost of revenues   3,245,863    7,256,523    711,777    -    11,214,163 
Gross profit  $2,530,694   $3,781,523   $520,815   $14,172   $6,847,204 
Operating expenses                         
General and administrative   3,305,771    2,773,590    762,072    1,115,105    7,956,538 
Depreciation and amortization   65,525    302,070    148,250    -    515,845 
Research and development   521,579    -    25,279    -    546,858 
Operating (loss)/income  $(1,362,181)  $705,863   $(414,786)  $(1,100,933)  $(2,172,037)
                          
Other income/(expense), net  $(51,468)   1,967,994   $-   $1,551,185   $3,467,711 

 

   Security   Industrial Services   Aerospace and Defense   Corporate   Consolidated 
   Three months ended March 31, 2025 
   Reportable Segments         
   Security   Industrial Services   Aerospace and Defense   Corporate   Consolidated 
External revenues  $16,981,152   $10,269,117   $    -   $-   $27,250,269 
Cost of revenues   8,177,296    6,907,518    -    -    15,084,814 
Gross profit  $8,803,856   $3,361,599   $-   $-   $12,165,455 
Operating expenses                         
General and administrative   3,655,756    2,229,023    -    575,661    6,460,440 
Depreciation and amortization   85,433    224,869    -    -    310,302 
Research and development   777,889    -    -    -    777,889 
Operating income/(loss)  $4,284,778   $907,707   $-   $(575,661)  $4,616,824 
                          
Other (expense)/income, net  $(493,731)   (110,145)  $-   $4,708,087   $4,104,211 

 

17
 

 

   Security   Industrial Services   Aerospace and Defense   Corporate   Consolidated 
   Six months ended March 31, 2026 
   Reportable Segments         
   Security   Industrial Services   Aerospace and Defense   Corporate   Consolidated 
External revenues  $11,288,085   $21,649,202   $1,232,592   $24,799   $34,194,678 
Cost of revenues   6,596,623    14,417,208    711,777    -    21,725,608 
Gross profit  $4,691,462   $7,231,994   $520,815   $24,799   $12,469,070 
Operating expenses                         
General and administrative   7,909,694    4,563,329    762,072    2,324,733    15,559,828 
Depreciation and amortization   145,561    545,335    148,250    -    839,146 
Research and development   1,023,014    -    25,279    -    1,048,293 
Operating (loss)/income  $(4,386,807)  $2,123,330   $(414,786)  $(2,299,934)  $(4,978,197)
                          
Other (expense)/income, net  $(115,642)  $1,918,577   $-   $(15,850,876)  $(14,047,941)

 

   Security   Industrial Services   Aerospace and Defense   Corporate   Consolidated 
   Six months ended March 31, 2025 
   Reportable Segments         
   Security   Industrial Services   Aerospace and Defense   Corporate   Consolidated 
External revenues  $22,434,851   $18,555,317   $    -   $-   $40,990,168 
Cost of revenues   10,791,236    12,331,541    -    -    23,122,777 
Gross profit  $11,643,615   $6,223,776   $-   $-   $17,867,391 
Operating expenses                         
General and administrative   7,415,054    3,990,426    -    1,810,526    13,216,006 
Depreciation and amortization   171,456    476,569    -    -    648,025 
Research and development   1,667,972    -    -    -    1,667,972 
Operating income/(loss)  $2,389,133   $1,756,781   $-   $(1,810,526)  $2,335,388 
                          
Other (expense)/income, net  $(886,648)  $(188,371)  $-   $(21,086,027)  $(22,161,046)

 

The following table summarizes the Company’s identifiable assets by segment as of March 31, 2026, and September 30, 2025.

 

   March 31, 2026   September 30, 2025 
       
Identifiable Assets          
Security  $14,568,187   $17,334,365 
Industrial Services   34,001,213    25,865,577 
Aerospace and Defense   8,466,640    - 
Corporate   13,700,334    4,588,334 
Total Assets  $70,736,374   $47,788,276 

 

NOTE 6 – RESTRICTED CASH

 

A subsidiary of the Company participates in a consortium in order to self-insure group care coverage for its employees. The plan is administrated by Benecon Group, and the Company makes monthly deposits in a trust account to cover medical claims and any administrative costs associated with the plan. Additionally, there was restricted cash in escrow per the purchase agreement with Heisey Mechanical Ltd. Additionally, there are funds in escrow related to bond requirements on certain public projects and deposit guarantees.

 

18
 

 

The Company’s restricted cash as of March 31, 2026, and September 30, 2025, are summarized below.

 

   March 31, 2026   September 30, 2025 
       
Benecon group  $972,865   $839,215 
Heisey escrow   -    100,000 
Bond escrow   304,145    366,319 
Deposit guarantees   66,078    67,204 
Restricted cash   $1,343,088   $1,372,738 

 

NOTE 7 – FAIR VALUE MEASUREMENTS

 

Fair value is defined as the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A three-level hierarchy is applied to prioritize the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

 

The three levels of the fair value hierarchy under the guidance for fair value measurements are described below:

 

Level 1 — Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date. Our Level 1 assets include cash equivalents, banker’s acceptances, trading securities, investments, and investment funds. The Company measures trading securities investments and investment funds at quoted market prices as they are traded in an active market with sufficient volume and frequency of transactions.

 

Level 2 — Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. If the asset or liability has a specified contractual term, a Level 2 input must be observable for substantially the full term of the asset or liability.

 

Level 3 — Level 3 inputs are unobservable inputs for the asset or liability in which there is little, if any, market activity for the asset or liability at the measurement date. Level 3 assets and liabilities include cost method investments. Quantitative information for Level 3 assets and liabilities reviewed at each reporting period includes indicators of significant deterioration in the earnings performance, credit rating, asset quality, business prospects of the investee, and financial indicators of the investee’s ability to continue as a going concern.

 

19
 

 

The Company’s fair value liabilities at March 31, 2026, and September 30, 2025, are as follows.

 

   Quoted Prices   Significant       
   in Active   Other   Significant   Balance 
   Markets for   Observable   Unobservable   as of 
   Identical Assets   Inputs   Inputs   March 31, 
   (Level 1)   (Level 2)   (Level 3)   2026 
Assets                                
Digital assets - SOL  $           1,085,163   $-   $-   $1,085,163 
Marketable Securities  $5,030,448   $-   $-   $5,030,448 
Liabilities                    
Warrant liabilities  $196,823   $546,676   $-   $743,499 

 

   Quoted Prices   Significant         
   in Active   Other   Significant   Balance 
   Markets for   Observable   Unobservable   as of 
   Identical Assets   Inputs   Inputs   September 30, 
   (Level 1)   (Level 2)   (Level 3)   2025 
                 
Assets                                                          
Digital assets - SOL  $1,158,238   $-   $-   $1,158,238 
Liabilities                    
Warrant liabilities  $833,854   $7,901,343   $-   $8,735,197 

 

Digital Assets – SOL

 

On July 29, 2025, and January 7, 2026, the Company invested $998,642, and 1,000,567, respectively, in Solana (SOL) and staked our holdings. SOL is a fungible crypto asset that meets the criteria for an intangible asset, resides on a distributed ledger, is secured by cryptography, and does not grant enforceable rights to underlying goods or services to its holder. The digital assets were measured at fair value after acquisition, with changes reported in net income. Staking earnings are recorded as revenue.

 

Digital Asset staking allows holders of specific cryptocurrencies to earn rewards for helping to validate blocks of transaction data as it is submitted to the blockchain network.

 

The staking process serves two key purposes:

 

  Ensures the accuracy of new information as it is added to the blockchain.
  Helps to secure the underlying blockchain network against the majority of the network taking over control, known as a 51% attack.

 

The staking process uses incentives and penalties governed by computer-based rules to encourage honest participation in the network. Stakers who act within the rules of the protocol receive rewards for their contributions, while those who act dishonestly can face penalties, such as losing their staked cryptocurrency through a process called slashing. Staking rewards are distributed as newly minted cryptocurrency units, oftentimes at a proportionate rate to the amount a person stakes. With some proof-of-stake blockchains, depositing more assets in a staking smart contract increases the chance of being selected to validate blocks. This mechanism is based on the assumption that those with more “skin in the game” are more likely to act within the best interests of the network because they have more to lose financially if their assets are slashed (confiscated by the network). However, to avoid favoring wealthier participants, some protocols incorporate randomness to ensure everyone, including those with smaller stakes, has a chance to earn rewards.

 

20
 

 

Staking incentives, in the form of additional SOL, are recognized on the date received at the fair market value on that date. There are no lockups or restrictions on the Company’s digital asset holdings due to staking.

 

The Company’s digital assets as of March 31, 2026, and September 30, 2025, are as follows.

 

   March 31, 2026   September 30, 2025 
Units - SOL   13,058    5,549 
Cost Per Unit  $155.74   $181.70 
Cost Basis  $2,033,595   $1,008,229 
Fair Value  $1,085,163   $1,158,238 

 

The following table is a summary of our digital assets as of March 31, 2026.

 

Fair Value, September 30, 2025  $1,158,238 
Cash purchase   1,000,567 
Receipt of SOL from staking   31,683 
Non-cash transaction fees   (6,884)
Unrealized loss   (1,098,441)
Fair Value, March 31, 2026  $1,085,163 

 

Marketable Securities

 

Marketable securities utilizing Level 1 inputs include active exchange-traded equity securities and equity index funds, as these securities all have quoted prices in active markets. These marketable securities are trading securities and are recorded at fair value. Unrealized gains and losses are reported under the caption other income/(expense), net on the Company’s Condensed Consolidated Statements of Operations.

 

Warrant Liabilities

 

The value of the Series A Warrants is based on the market value of our common stock on the balance sheet date.

 

The fair value of the Series B Warrants is estimated on the balance sheet date using the Black-Scholes model, which requires inputs based on certain subjective assumptions, including the fair value of the Company’s common shares, expected share price volatility, the expected term of the award, the risk-free interest rate for a period that approximates the expected term of the option, and the Company’s expected dividend yield.

 

At March 31, 2026, and September 30, 2025, the following inputs were used in the Black-Scholes model.

 

   March 31, 2026   September 30, 2025 
Expected term   3.09 Years    3.59 Years 
Risk-free interest rate   3.81%   3.61%
Expected volatility   185.85%   178.98%
Expected dividend yield   0.00%   0.00%
Exercise Price  $2.25   $5.30 

 

21
 

 

The following table summarizes information on warrant liabilities as of March 31, 2026.

 

   Series A Warrants   Series B Warrants   Total 
Warrant Liabilities at September 30, 2025  $833,854   $7,901,343   $8,735,197 
Warrants Issued   -    -    - 
Warrants Exercised   (97,614)   (5,608,273)   (5,705,887)
Fair market revaluation   (539,417)   (1,746,394)   (2,285,811)
Warrant Liabilities at March 31, 2026  $196,823   $546,676   $743,499 

 

NOTE 8 – TRADE RECEIVABLES, NET

 

Trade receivables, net consisted of the following:

 

   March 31, 2026   September 30, 2025 
       
Trade receivables  $13,475,565   $13,285,839 
Allowance for credit losses   (150,006)   (152,415)
Trade receivables, net  $13,325,559   $13,133,424 

 

Trade receivables include amounts due for shipped products and services rendered.

 

Allowance for credit losses include estimated losses resulting from the inability of our customers to make the required payments.

 

NOTE 9 – PREPAID EXPENSES AND OTHER CURRENT ASSETS

 

Prepaid expenses and other current assets consisted of the following:

 

   March 31, 2026   September 30, 2025 
         
Prepaid expenses  $1,307,009   $1,327,463 
Prepaid inventory   334,286    81,820 
Deferred costs   379,797    132,434 
Short-term investments   -    14,715 
Prepaid income taxes   146,117    - 
Prepaid expenses and other current assets total  $2,167,209   $1,556,432 

 

NOTE 10 – INVENTORY, NET

 

Inventory, net consisted of the following:

 

   March 31, 2026   September 30, 2025 
       
Raw materials  $680,252   $609,304 
Work in progress   464,337    364,907 
Finished goods   5,595,990    5,610,733 
Inventory, net   6,740,579    6,584,944 

 

22
 

 

The Company maintained an allowance for obsolete inventories of $1,019,828 and $1,034,798 at March 31, 2026, and September 30, 2025, respectively.

 

NOTE 11 – PROPERTY AND EQUIPMENT

 

Property and equipment are summarized as follows:

 

   March 31, 2026   September 30, 2025 
       
Land  $1,854,511   $945,279 
Building and leasehold improvements   8,744,992    4,482,978 
Furniture and office equipment   650,194    625,995 
Computers and software   2,654,119    2,685,331 
Machinery and equipment   16,443,751    13,927,502 
Property and equipment, gross   30,347,567    22,667,085 
Less: Accumulated depreciation   (13,806,618)   (13,015,089)
Property and equipment, net  $16,540,949   $9,651,996 

 

Depreciation expense for the three months ended March 31, 2026, and 2025, was $458,939 and $319,507, respectively, depreciation expense for the six months ended March 31, 2026, and 2025, was $877,126 and $666,252, respectively, and is recorded in cost of revenues and general and administrative expenses on the Company’s unaudited condensed consolidated statements of operations.

 

NOTE 12 – GOODWILL AND INTANGIBLE ASSETS

 

Changes in the carrying amount of goodwill, by segment, were as follows:

 

   Security   Industrial Services   Aerospace and Defense   Consolidated 
Balance at September 30, 2025  $-   $3,708,347   $-   $3,708,347 
Impairment /adjustments   -    -    -    - 
Acquisitions   -    -    3,977,794    3,977,794 
Balance at March 31, 2026  $-   $3,708,347   $3,977,794   $7,686,141 

 

As of March 31, 2026, and September 30, 2025, accumulated impairment losses of $3,846,475 have been recorded related to the Security segment.

 

On January 8, 2026, the Company acquired Invocon, as part of the fair market evaluation for the purchase price accounting, the company recognized intangible assets in the form of the company trade name and internal developed technologies.

 

Changes in the carrying amount of intangible assets, by segment, were as follows:

 

   Security   Industrial Services   Aerospace and Defense   Consolidated 
Balance at September 30, 2025  $     -   $        -   $-   $- 
Acquisitions   -    -    3,130,000    3,130,000 
Amortization   -    -    (148,250)   (148,250)
Balance at March 31, 2026  $-   $-   $2,981,750   $2,981,750 

 

NOTE 13 – OTHER ASSETS

 

On November 13, 2020, and January 19, 2022, Cemtrex made $500,000 in investments, on July 18, 2023, and October 5, 2023, made additional $100,000 in investments, and on October 17, 2024, and November 18, 2024, made additional $50,000 in investments on each respective date, via a simple agreement for future equity (“SAFE”) in MasterpieceVR. The SAFE provides that the Company will automatically receive shares of the entity based on the conversion rate of future equity rounds up to a valuation cap, as defined. MasterpieceVR is a software company that is developing software for content creation using virtual reality. The investment is included in other assets in the accompanying unaudited condensed consolidated balance sheet and the Company accounts for this investment and records it at cost. No impairment has been recorded for the six months ended March 31, 2026, and 2025.

 

23
 

 

Other assets consisted of the following:

 

   March 31, 2026   September 30, 2025 
Rental deposits  $259,619   $262,201 
Investment in Masterpiece VR   1,300,000    1,300,000 
Other deposits   51,249    63,930 
Demonstration equipment supplied to resellers   -    441,624 
Other assets total  $1,610,868   $2,067,755 

 

NOTE 14 – ACCRUED EXPENSES

 

Accrued expenses consisted of the following:

 

   March 31, 2026   September 30, 2025 
Accrued expenses  $1,305,722   $442,344 
Accrued payroll and payroll taxes   1,026,684    1,558,475 
Accrued warranty   222,702    222,702 
Accrued expenses total  $2,555,108   $2,223,521 

 

NOTE 15 – DEFERRED REVENUE

 

The Company’s deferred revenue for the three and six months ended March 31, 2026, and 2025, were as follows:

 

   For the three months ended   For the six months ended 
   March 31, 2026   March 31, 2025   March 31, 2026   March 31, 2025 
                 
Deferred revenue at beginning of period  $1,683,471   $1,766,705   $1,866,014   $1,955,635 
Net additions:                    
Deferred software revenues   233,696    445,382    607,796    809,527 
Recognized as revenue:                    
Deferred software revenues   (526,265)   (522,669)   (1,082,908)   (1,075,744)
Deferred revenue at end of period   1,390,902    1,689,418    1,390,902    1,689,418 
Less: current portion   1,019,351    1,179,536    1,019,351    1,179,536 
Long-term deferred revenue at end of period  $371,551   $509,882   $371,551   $509,882 

 

For the three months ended March 31, 2026, and 2025, the Company recognized revenue of $495,402 and $501,666, respectively. For the six months ended March 31, 2026, and 2025, the Company recognized revenue of $914,003, and $885,962, respectively, that was previously included in the beginning balance of deferred revenues.

 

NOTE 16 – CONTRACT ASSETS AND LIABILITIES

 

Project contracts typically provide for a schedule of billings on percentage of completion of specific tasks inherent in the fulfillment of the Company’s performance obligation(s). The schedules for such billings usually do not precisely match the schedule on which costs are incurred. As a result, contract revenue recognized in the statements of operations can and usually does differ from amounts that can be billed to the customer at any point during the contract. Amounts by which cumulative contract revenue recognized on a contract as of a given date exceeds cumulative billings and unbilled receivables to the customer under the contract are reflected as a current asset in the unaudited condensed consolidated balance sheets under the caption “Contract assets.” Amounts by which cumulative billings to the customer under a contract as of a given date exceed cumulative contract revenue recognized are reflected as a current liability in the unaudited condensed consolidated balance sheets under the caption “Contract liabilities.” Conditional retainage represents the portion of the contract price withheld until the work is substantially complete for assurance of the Company’s obligations to complete the job.

 

24
 

 

The following is a summary of the Company’s uncompleted contracts:

 

   March 31, 2025   September 30, 2025 
Costs incurred on uncompleted contracts  $21,695,817   $10,344,923 
Estimated gross profit   6,457,872    4,025,531 
    28,153,689    14,370,454 
Applicable billings to date   (28,293,504)   (15,045,345)
Net earnings in excess of billings/(billing in excess of costs)  $(139,815)  $(674,891)

 

For the three and six months ended March 31, 2026, and 2025, the Company recognized revenue of $130,471 and $342,725, and $1,402,348 and $1,103,156, respectively, that was previously included in the beginning balance of contract liabilities.

 

The following table summarizes the net activity of the contract assets and contract liabilities for the three and six months ended March 31, 2026, and 2025.

 

   March 31, 2026   March 31, 2025   March 31, 2026   March 31, 2025 
   For the three months ended   For the six months ended 
   March 31, 2026   March 31, 2025   March 31, 2026   March 31, 2025 
Costs and Estimated Earnings in Excess of Billings on Uncompleted Contracts                    
Contract asset, beginning balance  $1,697,691   $1,541,241   $980,164   $985,207 
Changes in revenue billed, contract price or cost estimates   (151,007)    (384,621)   566,520    171,413 
Contract assets acquired in acquisition   661,885    -    661,885    - 
Contract asset, net, ending balance  $2,208,569   $1,156,620   $2,208,569   $1,156,620 
Billings in Excess of Costs and Estimated Earnings on Uncompleted Contracts                    
Contract liability, beginning balance   (1,542,262)  $(1,279,187)   (1,655,055)  $(1,254,204)
Changes in revenue billed, contract price or cost estimates   (273,585)    (645,238)   (160,792)   (670,221)
Contract liabilities acquired in acquisition   (532,537)   -    (532,537)   - 
Contract liability, ending balance  $(2,348,384)  $(1,924,425)  $(2,348,384)  $(1,924,425)
Net Billings in Excess of Costs and Estimated Earnings on Uncompleted Contracts                    
Net billings in excess of costs, beginning balance  $155,429   $262,054   $(674,891)  $(268,997)
Changes in revenue billed, contract price or cost estimates   (424,592)    (1,029,859)   405,728    (498,808)
Net billings in excess of costs acquired in acquisition   129,348    -    129,348    - 
Net (earnings in excess of billings)/costs in excess of billings, ending balance  $(139,815)  $(767,805)  $(139,815)  $(767,805)

 

NOTE 17 – RELATED PARTY TRANSACTIONS

 

On November 22, 2022, the Company entered into two Asset Purchase Agreements and one Simple Agreement for Future Equity (“SAFE”) with the Company’s CEO, Saagar Govil, to secure the sale of the subsidiaries Cemtrex Advanced Technologies, Inc, which include the brand SmartDesk, and Cemtrex XR, Inc., which include the brands Cemtrex XR, Virtual Driver Interactive, Bravo Strong, and good tech (formerly Cemtrex Labs), to Mr. Govil.

 

On January 6, 2025, the Company and Saagar Govil signed an agreement to revise the purchase price structure and payment terms.

 

The Agreement’s Purchase Price provisions were amended to reflect that the Purchase Price will solely consist of the royalties based on the actual revenues generated in the three years following closing. The provision requiring the total sum of royalties to reach a minimum of $820,000, with any shortfall to be paid by Purchaser, was removed from the Agreement.

 

Additionally, it was agreed that the payment terms due under the royalties shall be as follows commencing on January 1, 2025:

 

First Year (January 2025) Monthly Payment: $10,000
Second Year (January 2026) Monthly Payment: $20,000
Balloon Payment at the end of the Second Year (December 31, 2026): Total outstanding royalties

 

This transaction was approved by the Board of Directors with Saagar Govil abstaining from the vote.

 

25
 

 

Based on the new payment terms, management determined that it was appropriate to remove the previously recognized royalty receivable of $280,545 from the financial statements as of December 31, 2024.

 

As of March 31, 2026, there were royalties receivable from the sale of Cemtrex, XR, Inc. of $664,000, all of which is considered short-term and is presented on the Company’s unaudited Condensed Consolidated Balance Sheet under the caption “Trade receivables, net – related party. The Company has taken a $381,550 allowance for expected credit losses against these royalties.

 

As of March 31, 2026, there was $548,554 in trade receivables due from the Cemtrex XR successor company, CXR, Inc. Of these receivables $282,450 is the net due on the royalties on CXR Inc.’s revenues. The remaining $266,104 is related to the services provided by Vicon Security Technologies Pvt Ltd. (formerly Cemtrex Technologies Pvt. Ltd.) in the normal course of business. During the year ended September 30, 2025, the Company recorded $60,628 in current expected credit losses on receivables due from CXR Inc.

 

NOTE 18 – EXPECTED CREDIT LOSSES

 

The following table summarized the Company’s activity for expected credit losses for the six months ended March 31, 2026.

 

   Trade receivables, net   Contract assets, net   Royalties receivable, net - related party 
As of September 30, 2025  $152,415   $9,704   $165,771 
Provision   -    10,395    215,779 
Recovery   (2,409)   -    - 
Write-off   -    -    - 
As of March 31, 2026  $150,006   $20,099   $381,550 

 

NOTE 19 – LEASES

 

The Company is party to contracts where we lease property from others under contracts classified as operating leases. The Company primarily leases office and operating facilities, vehicles, and office equipment. The weighted average remaining term of our operating leases was approximately 3.23 years at March 31, 2026, and 3.30 years at March 31, 2025. The weighted average discount rate used to measure lease liabilities was approximately 6.16% at March 31, 2026, and 6.22% at March 31, 2025. The Company used the rate implicit in the lease, where known, or its incremental borrowing rate as the rate used to discount the future lease payments.

 

The Company has a single lease that is classified as a finance lease for equipment acquired as part of the Richland acquisition. The remaining term of this lease is 0.58 years with a discount rate of 1.76% as of March 31, 2026.

 

The Company has elected not to recognize lease assets and liabilities for leases with a term of 12 months or less.

 

The Company’s security segment leases approximately 350 square feet of office space in Clovis, CA on a month-to-month lease at a rent of $2,075 per month. Short-term rent expense was $12,840 for the six months ended March 31, 2026, and $25,671 for the six months ended March 31, 2025.

 

26
 

 

A reconciliation of undiscounted cash flows to finance and operating lease liabilities recognized in the unaudited condensed consolidated balance sheet at March 31, 2026, is set forth below:

 

Years ending September 30,  

Finance Leases

   Operating Leases 
Remainder of 2026   $ 335,027    $728,754 
2027     -     1,170,804 
2028     -     560,383 
2029     -     372,750 
2030 and thereafter     -     380,672 
Undiscounted lease payments     335,027     3,213,363 
Amount representing interest     (3,209 )   (322,629)
Discounted lease payments     331,818     2,890,734 
Less short-term lease liabilities     331,818     1,249,135 
Long-term lease liabilities   $ -    $1,641,599 

 

Lease costs for the three and six months ended March 31, 2026, and 2025 are set forth below:

 

   2026   2025   2026   2025 
   For the three months ended   For the six months ended 
   March 31,   March 31, 
   2026   2025   2026   2025 
Operating lease costs:                    
Amortization of right-of-use assets   313,479    206,795    571,248    461,490 
Interest on lease obligations   5,624    1,820    10,860    3,396 
Operating lease costs total   319,103    208,615    582,108    464,886 
Finance lease costs                    
Amortization of right-of-use assets   9,503    -    9,503    - 
Interest on lease obligations   496    -    496    - 
Finance lease costs total   9,999    -    9,999    - 
Short-term lease costs   6,420    11,265    12,840    25,671 
Total lease cost  $335,522   $219,880   $604,947   $490,557 
                     
Other information:                    
Cash paid for amounts included in the measurement of lease liabilities:                    
Operating leases  $319,103   $208,615   $582,108   $464,886 
Finance lease  $6,897   $-   $6,897   $- 

 

NOTE 20 – LINES OF CREDIT AND LONG-TERM LIABILITIES

 

Revolving line of credit

 

On October 5, 2023, the Company obtained a revolving line of credit in the amount of $5,000,000 from Pathward, N.A.. The interest rate will be a rate which is equal to three percentage points (3%) in excess of that rate shown in the Wall Street Journal as the prime rate (the “Effective Rate”) matures twenty-four months from the closing date, and if not specifically terminated, renews for one-year periods.  This loan is secured by the Company’s eligible accounts receivable and eligible finished goods inventory. The Company’s ability to borrow against the line of credit is limited by the value of the eligible assets. As of March 31, 2026, the Company had enough eligible assets to access approximately $3,100,000 of the credit line. The Company was in compliance with all loan covenants as of March 31, 2026. As of March 31, 2026, and September 30, 2025, this loan had a balance of $2,035,697, and $3,176,096, respectively.

 

Notes payable

 

On November 7, 2025, the Company issued a note payable to Streeterville Capital, LLC in the amount of $7,025,000. This note carries interest between November 7, 2025, and December 31, 2025, of SOFR (3.87% as of December 31, 2025), after December 31, 2025, 8%, This Note matures eighteen (18) months from the issuance date with redemptions of up to $700,000 a month beginning at six (6) months from the issuance date. After deduction of legal fees of $25,000, the Company received $7,000,000 in cash. Additionally, this note contains an additional interest provision that if this note is outstanding on January 1, 2026, a one-time additional interest fee of $1,050,00 which is being amortized over the remaining life of the loan, as of March 31, 2026, there is $853,125 of unamortized interest. As of March 31, 2026, this note had a balance of $8,281,006.

 

27
 

 

On February 5, 2026, the company issued a promissory note to Fulton Bank in the amount of $600,000 for the purchase of Richland Industries, LLC. This note carries interest of 6.09% requires 60 monthly payments of interest and principal and matures on February 1, 2031. As of March 31, 2026, the note had a balance of $590,787.

 

On February 5, 2026, the Company acquired a mortgage in the amount of $3,920,000 from Fulton Bank to finance the purchase of the property formerly owned by Richland Industries, LLC. The mortgage carries interest at the Secured Overnight Financing Rate (SOFR) plus 2.75% and matures on February 1, 2046. As of March 31, 2026, this loan had a balance of $3,912,200.

 

The following table outlines the Company’s secured liabilities:

 

           March 31,   September 30, 
   Interest Rate   Maturity   2026   2025 
Fulton Bank - $312,000 fund equipment for AIS. This loan is secured by certain assets of the Company.  SOFR plus 2.37% (6.05% as of March 31, 2026 and 6.61% as of September 30, 2025).   9/30/2029    228,921    257,704 
Fulton Bank - $312,000 fund equipment for AIS. This loan is secured by certain assets of the Company.  SOFR plus 2.37% (6.05% as of March 31, 2026 and 6.61% as of September 30, 2025).   9/30/2029    228,921    257,704 
                   
Fulton Bank mortgage $2,476,000. This loan is secured by the underlying asset.  SOFR plus 2.62% (6.30% on March 31, 2026 and 6.86% on September 30, 2025).    1/28/2040    1,989,603    2,034,048 
                   
Fulton Bank (HEISEY) - $1,200,000 mortgage loan; requires monthly principal and interest payments through August 1, 2043 with a final payment of remaining principal on September 1, 2043; The loan is collateralized by 615 Florence Street and 740 Barber Street and guaranteed by AIS and Cemtrex.  SOFR plus 2.80% per annum (6.48% as of March 31, 2026 and 7.04% as of September 30, 2025).   9/30/2043    1,129,836    1,146,630 
                   
Fulton Bank (HEISEY) - $2,160,000. promissory note related to purchase of Heisey; requires 84 monthly principal and interest payments; The note is collateralized by the Heisey assets and guaranteed by Cemtrex; matures in 2030.  SOFR plus 2.80% per annum (6.48% as of March 31, 2026 and 7.04% as of September 30, 2025).   7/1/2030    1,469,944    1,613,677 
                   
Fulton Bank (AIS - TN) - $3,920,000 mortgage loan; requires monthly principal and interest payments through January 1, 2046 with a final payment of remaining principal on February 1, 2046; The loan is collateralized by 1905 Mines Rd. and guaranteed by AIS and Cemtrex.  SOFR plus 2.75% per annum (6.43% as of March 31, 2026).   2/1/2046    3,912,200     
                   
Fulton Bank (AIS - TN) - $600,000. promissory note related to purchase of AIS - TN; requires 60 monthly principal and interest payments; The note is collateralized by the AIS - TN assets and guaranteed by AIS and Cemtrex; matures in 2031.  6.09%  2/1/2031    590,787     
                   
Note payable - $9,205,000. Less original issue discount $1,200,000 and legal fees $5,000,net cash received $8,000,000. 28,572 shares of common stock valued at $700,400 recognized as additional original issue discount. Unamortized original issue discount balance of $0 as of September 30, 2025 and September 30, 2024.  8%  2/22/2027    138,072    7,871,777 
                   
Note payable - $580,000. Less original issue discount $75,000 and legal fees $5,000,net cash received $500,000. Unamortized original issue discount balance of $33,333 as of September 30, 2025.  8%  5/21/2026    647,433    621,773 
                   
Note payable - $7,025,000. Less legal fees $25,000,net cash received $7,000,000. A $1,050,000 additional interest provision was recorded on January 1, 2026  Between November 7, 2025 and December 31, 2025, SOFR (3.87% as of December 31, 2025), after December 31, 2025, 8%   5/6/2027    8,281,006    - 
                   
Less: Unamortized original issue discount           (861,458)   (33,333)
Total debt          $17,526,344   $13,512,276 
Less: Current maturities           (8,770,319)   (8,925,497)
Long-term debt          $8,756,025   $4,586,779 

 

28
 

 

NOTE 21 – STOCKHOLDERS’ EQUITY

 

Series 1 Preferred Stock

 

The Company’s Series 1 Preferred Stock is quoted on the OTC Markets OTCID tier under the symbol “CETXP.”

 

During the six months ended March 31, 2026, 135,592 shares of Series 1 Preferred Stock were issued to pay dividends to holders of Series 1 Preferred Stock.

 

As of March 31, 2026, and September 30, 2025, there were 2,840,919 and 2,705,327 shares of Series 1 Preferred Stock issued and 2,776,819 and 2,641,227 shares of Series 1 Preferred Stock outstanding, respectively.

 

Common Stock

 

On October 2, 2024, November 26, 2024, and September 29, 2025, the Company completed a 60:1, 35:1, and 15:1 respectively, reverse stock split on its common stock. All share and per share data have been retroactively adjusted for the reverse splits.

 

During the six months ended March 31, 2026, 29,943 shares of common stock were issued for the exercise 9,981 Series A Warrants, under the Alternative Cashless Exercise option as adjusted for exercise price adjustments. During the three months ended March 31, 2026, no Series A Warrants were exercised.

 

During the six months ended March 31, 2026, there 67,671 shares of common stock issued for rounding on the September 29, 2025, reverse stock split. During the three months ended March 31, 2026, no rounding shares were issued.

 

During the three and six months ended March 31, 2026, 8,030, and 2,324,510 shares of common stock were issued for the exercise of 8,030, and 2,324,510 Series B Warrants, respectively which generated $5,675,332 in proceeds.

 

During the six months ended March 31, 2026, 3,000,296 shares of the Company’s common stock have been issued to satisfy $7,759,168 of notes payable, $84,832 in accrued interest, and $11,798,283 of excess value of shares issued recorded as interest expense. Such shares were issued pursuant to the exemption contained under Section 4(a)(2) of the Securities Act of 1933, as amended. During the three months ended March 31, 2026, no shares were issued to satisfy debt.

 

29
 

 

Series A and Series B Warrants

 

The following table summarizes information about shares issuable under warrants outstanding as of March 31, 2026.

 

   Warrant Shares Outstanding   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term (in years) 
Outstanding at September 30, 2025   1,667,106   $4.84    3.37 
Warrants granted   -           
Warrants exercised   (2,354,453)  $2.41      
Warrants forfeited   -           
Warrants cancelled   -           
Exercise price adjustments   2,062,572           
Outstanding at March 31, 2026   1,375,225   $1.73    2.52 

 

On October 13, 2025, the Company issued shares of common stock to relieve debt. At the time, the Company had 147,324 Series A Warrants and 1,519,782 Series B Warrants outstanding at an exercise price of $5.304. According to the terms of the Series A and Series B warrants, in the event of a issuance below the current exercise price, the exercise price resets to the lower of (i) the public offering price, or (ii) the lowest VWAP during the period commencing five (5) consecutive trading days commencing on the republic offering effective date and the number of warrants are adjusted as to keep the aggregate value of the warrants then outstanding remains unchanged. On October 17, 2025, it was determined that the exercise price has reset to $4.56.

 

The following table illustrates the adjustment.

 

   Warrants outstanding   Aggregate Value   Adjusted number of warrants outstanding 
Series A Warrants   147,324   $260,467    57,120 
Series B Warrants   1,519,782   $8,061,006    1,767,778 

 

On December 11, 2025, the Company closed on a Securities Purchase agreement of common stock. At the time, the Company had 57,120 Series A Warrants and 1,757,778 Series B Warrants outstanding at an exercise price of $4.56. According to the terms of the Series A and Series B warrants, in the event of a public offering, the exercise price resets to the lower of (i) the public offering price, or (ii) the lowest VWAP during the period commencing five (5) consecutive trading days commencing on the republic offering effective date and the number of warrants are adjusted as to keep the aggregate value of the warrants then outstanding remains unchanged. On December 17, 2025, it was determined that the exercise price has reset to $2.433.

 

The following table illustrates the adjustment.

 

   Warrants outstanding   Aggregate Value   Adjusted number of warrants outstanding 
Series A Warrants   57,120   $260,467    107,058 
Series B Warrants   1,757,778   $8,015,406    3,294,469 

 

On December 30, 2025, the Company closed on a Securities Purchase agreement of common stock. At the time, the Company had 78,489 Series A Warrants and 987,987 Series B Warrants outstanding at an exercise price of $2.433. According to the terms of the Series A and Series B warrants, in the event of a public offering, the exercise price resets to the lower of (i) the public offering price, or (ii) the lowest VWAP during the period commencing five (5) consecutive trading days commencing on the republic offering effective date and the number of warrants are adjusted as to keep the aggregate value of the warrants then outstanding remains unchanged. On January 6, 2026, it was determined that the exercise price has reset to $2.25.

 

30
 

 

The following table illustrates the adjustment.

 

   Warrants outstanding   Aggregate Value   Adjusted number of warrants outstanding 
Series A Warrants   78,489   $236,183    104,792 
Series B Warrants   987,987   $2,403,749    1,068,339 

 

For the six months ended March 31, 2026, and 2025 the company recognized a loss on the fair value of the common shares issued for the exercised warrants of $4,658,582 and a loss of $15,796,105, respectively, which represents the difference between the fair value of the shares issued and the value of the warrants exercised.

 

For the six months ended March 31, 2026, and 2025 the company recognized a loss on changes in fair value of warrant liability of $688,671, and $10,020,212, respectively, which represents the change in the fair value of the of the warrants unexercised at the measurement period.

 

Equity Offerings

 

On December 11, 2025, the Company entered into a Securities Purchase Agreement with a single accredited institutional investor pursuant to which the Company agreed to issue and sell to the Purchaser, in a registered direct offering securities consisting of shares of the Company’s common stock, par value $0.001 per share, and/or pre-funded warrants to purchase shares of Common Stock at $3.00 per share/warrant for aggregate gross proceeds of $2,000,000. The Offering closed on December 11, 2025. The Company issued 310,000 shares of common stock and prefunded warrants to purchase 356,667 shares of common stock. The Prefunded warrants were immediately exercised, and the Company issued 666,667 shares of common stock in the aggregate.

 

On December 23, 2025, the Company entered into a Securities Purchase Agreement with a single accredited institutional investor pursuant to which the Company agreed to issue and sell to the Purchaser, in a registered direct offering securities consisting of shares of the Company’s common stock, par value $0.001 per share, and/or pre-funded warrants to purchase shares of Common Stock at $2.50per share/warrant for aggregate gross proceeds of $2,000,000. The Offering closed on December 23, 2025. The Company issued 330,000 shares of common stock and prefunded warrants to purchase 470,000 shares of common stock. The Prefunded warrants were immediately exercised, and the Company issued 800,000 shares of common stock in the aggregate.

 

On December 30, 2025, the Company entered into a Securities Purchase Agreement with a single accredited institutional investor pursuant to which the Company agreed to issue and sell to the Purchaser, in a registered direct offering securities consisting of shares of the Company’s common stock, par value $0.001 per share, and/or pre-funded warrants to purchase shares of Common Stock at $2.25 per share/warrant for aggregate gross proceeds of $2,000,000. The Offering closed on December 30, 2025. The Company issued 330,000 shares of common stock and prefunded warrants to purchase 548,889 shares of common stock. The Prefunded warrants were immediately exercised, and the Company issued 888,889 shares of common stock in the aggregate.

 

On January 9, 2026, Cemtrex, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a single accredited institutional investor (the “Purchaser”), pursuant to which the Company agreed to issue and sell to the Purchaser, in a registered direct offering (the “Offering”), securities consisting of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and/or pre-funded warrants to purchase shares of Common Stock (the “Pre-Funded Warrants”), for aggregate gross proceeds of $4,000,000. The Offering closed on January 9, 2026. The Company issued 400,000 shares of common stock and prefunded warrants to purchase 1,069,507 shares of common stock, all the prefunded warrants were immediately exercised.

 

31
 

 

NOTE 22 – SHARE-BASED COMPENSATION

 

For the six months ended March 31, 2026, and 2025, the Company recognized $0 and $7,183 of share-based compensation expense on its outstanding options, respectively. As of March 31, 2026, there was no unrecognized share-based compensation expense.

 

During the six months ended March 31, 2026, no options were granted, cancelled, or forfeited.

 

NOTE 23 – COMMITMENTS AND CONTINGENCIES

 

From time to time, the Company and its subsidiaries are involved in legal proceedings that are incidental to the operation of our business. The Company continues to defend vigorously against all claims. Although the ultimate outcome of any legal matter cannot be predicted with certainty, based on present information, including assessment of the merits of the particular claim, as well as current accruals and insurance coverage, the Corporation does not expect that such legal proceedings will have a material adverse impact on its unaudited condensed consolidated financial statements.

 

NOTE 24 – INCOME TAXES

 

For the three and six months ended March 31, 2026, and 2025, the Company recorded an income tax expense of approximately $73,859 and $110,525, 340,185, and 231,063, respectively. These taxes are related to our international operations and state taxes of certain subsidiaries.

 

As of year-end 2025, the Company had federal, state, and foreign net operating losses (“NOL”) of approximately $68.9 million, $84.0 million, and $9.8 million, respectively. The Company has pre 2018 TCJA NOLs and post 2017 TCJA NOLs. Pre 2018 NOLs will expire in 20 years with the first amount expiring in 2030 and the post 2017 NOLs can be carried forward indefinitely. Generally, state NOLs have different NOL carryforward rules, with some pre-2018 NOLs being able to be carried forward indefinitely. The first amount of state NOLs begin to expire in 2026. In accordance with Section 382 of the U.S. Internal Revenue Code, the usage of the Company’s NOL carryforwards is subject to annual limitations following greater than 50% ownership changes. Tax returns for the years ended 2022 through 2025 are subject to review by tax authorities.

 

The Company’s effective tax rates for the three and six months ended March 31, 2026, and 2025, were (5.7%) and 1.27%, (1.79%) and (1.17%) respectively.

 

NOTE 25 – SUBSEQUENT EVENTS

 

On April 7, 2026, the Company issued 864,588 shares of the Company’s common stock to satisfy $580,000 of notes payable, $68,441 in accrued interest, and $466,878 of excess value of shares issued recorded as interest expense. Such shares were issued pursuant to the exemption contained under Section 4(a)(2) of the Securities Act of 1933, as amended.

 

On April 17, 2026, the Company issued 150,000 shares of the Company’s common stock were issued for the exercise of 150,000 Series B Warrants which generated $112,500 in proceeds.

 

On May 8, 2026, the Company issued 29,157 shares of the Company’s common stock to satisfy $25,000 of accrued interest on notes payable, and $950 of excess value of shares issued recorded as interest expense. Such shares were issued pursuant to the exemption contained under Section 4(a)(2) of the Securities Act of 1933, as amended.

 

32
 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Except for historical information contained in this report, the matters discussed are forward-looking statements that involve risks and uncertainties. When used in this report, words such as “anticipates”, “believes”, “could”, “estimates”, “expects”, “may”, “plans”, “potential” and “intends” and similar expressions, as they relate to the Company or its management, identify forward-looking statements. Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. Such forward-looking statements are based on the beliefs of the Company’s management, as well as assumptions made by and information currently available to the Company’s management. Among the factors that could cause actual results to differ materially are the following: the effect of business and economic conditions; the impact of competitive products and their pricing; unexpected manufacturing or supplier problems; the Company’s ability to maintain sufficient credit arrangements; changes in governmental standards by which our environmental control products are evaluated and the risk factors reported from time to time in the Company’s SEC reports, including its recent report on Form 10-K. The Company undertakes no obligation to update forward-looking statements as a result of future events or developments.

 

General Overview

 

Cemtrex was incorporated in 1998 in the state of Delaware and has evolved through strategic acquisitions and internal growth into a leading multi-industry company. Unless the context requires otherwise, all references to “we”, “our”, “us”, “Company”, “registrant”, “Cemtrex” or “management” refer to Cemtrex, Inc. and its subsidiaries.

 

The Company’s reporting segments consist of Security and Industrial Services. Additionally, the Company’s operational structure also reports unallocated corporate expenses.

 

Security

 

Cemtrex’s Security segment operates under the brand of its majority owned subsidiary, Vicon Industries, Inc. (“Vicon”), which provides end-to-end security solutions to meet the toughest corporate, industrial, and governmental security challenges. Vicon’s products include browser-based video monitoring systems and analytics-based recognition systems, cameras, servers, and access control systems for every aspect of security and surveillance in industrial and commercial facilities, federal prisons, hospitals, universities, schools, and federal and state government offices. Vicon provides innovative, mission critical security and video surveillance solutions utilizing Artificial Intelligence (AI) based data algorithms.

 

Industrial Services

 

Cemtrex’s Industrial Services segment operates under the brand, Advanced Industrial Services (“AIS”), which offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. AIS installs high precision equipment in a wide variety of industrial markets like automotive, printing & graphics, industrial automation, packaging, and chemicals, among others. AIS is a leading provider of reliability-driven maintenance and contracting solutions for machinery, packaging, printing, chemical, and other manufacturing markets. The focus is on customers seeking to achieve greater asset utilization and reliability to cut costs and increase production from existing assets, including small projects, sustaining capital, turnarounds, maintenance, specialty welding services, and high-quality scaffolding.

 

Aerospace and Defense

 

Cemtrex’s Aerospace and Defense segment operates under the brand Invocon, which offers designing, manufacturing, and supporting advanced instrumentation, wireless sensing, and telemetry systems deployed across satellites, launch vehicles, target missiles, and space-based platforms. Its technologies support numerous government and prime contractor programs, including multiple Space Shuttle and International Space Station systems, and the company maintains long-standing relationships across the Missile Defense Agency and leading aerospace and defense primes.

 

33
 

 

Significant Accounting Policies and Estimates

 

Our discussion and analysis of our financial condition and results of operations are based upon the accompanying unaudited condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The preparation of financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses, and the related disclosures at the date of the financial statements and during the reporting period. Although these estimates are based on our knowledge of current events, our actual amounts and results could differ from those estimates. The estimates made are based on historical factors, current circumstances, and the experience and judgment of our management, who continually evaluate the judgments, estimates and assumptions and may employ outside experts to assist in the evaluations.

 

Certain of our accounting policies are deemed “significant”, as they are both most important to the financial statement presentation and require management’s most difficult, subjective, or complex judgments as a result of the need to make estimates about the effect of matters that are inherently uncertain. For a discussion of our significant accounting policies, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended September 30, 2025.

 

Results of Operations – For the three months ended March 31, 2026, and 2025

 

Revenues

 

The Company’s Security segment revenues for the three months ended March 31, 2026, decreased by $11,204,595 or 66% to $5,776,557 from $16,981,152 for the three months ended March 31, 2025. This decrease is mainly due to a large sale valued at $10,375,000 for security technology products under our Vicon brand during the quarter ended March 31, 2025.

 

The Company’s Industrial Services segment revenues for the three months ended March 31, 2026, increased by $768,929 or 7%, to $11,038,046 from $10,269,117, for the three months ended March 31, 2025. This increase is mainly due to the revenues from the acquisition of Richland, LLC.

 

The Company’s newly established Aerospace and Defense segment generated revenues of $1,232,592 for the three months ended March 31, 2026

 

There was unallocated revenue under the Corporate segment of $14,172 for the three months ended March 31, 2026. This revenue is related to the Company’s investment in digital assets.

 

Gross Profit

 

Gross Profit for the three months ended March 31, 2026, was $6,847,204 or 38% of revenues as compared to gross profit of $12,165,455 or 45% of revenues for the three months ended March 31, 2025.

 

Gross profit in our Security segment was $2,530,694 or 44% of the segment’s revenues for the three months ended March 31, 2026, as compared to gross profit of $8,803,856 or 52% of the segment’s revenues for the period ended March 31, 2025. Gross profit in our security segment decreased as a result of the large sale mentioned above, additionally gross profits have been impacted by tariffs and fuel surcharges on shipping. The Company is currently evaluating the potential impact of tariff refunds on future gross profit percentages.

 

Gross profit in our Industrial Services segment was $3,781,523 or 34% of the segment’s revenues for the three months ended March 31, 2026, as compared to gross profit of $3,361,599 or 33% of the segment’s revenues for the period ended March 31, 2025. Gross profit increased in the three months ended March 31, 2026, compared to the three months ended March 31, 2025, was mainly due to the acquisition of Richland, LLC which lowered outsourcing costs now provided by AIS – TN, formerly Richland LLC.

 

Gross profit in the Company’s newly established Aerospace and Defense segment was 520,815 or 42% of revenues for the three months ended March 31, 2026

 

34
 

 

General and Administrative Expenses

 

General and administrative expenses for the three months ended March 31, 2026, increased $1,701,641 or 25% to $8,472,383 from $6,770,742 for the three months ended March 31, 2025. The increase in general and administrative expenses is mainly related to the additional expenses related to the acquisition of Invocon and Richland.

 

Research and Development Expenses

 

Research and Development expenses for the three months ended March 31, 2026, were $546,858 compared to $777,889 for the three months ended March 31, 2025, a decrease of $231,031 or 30%. Research and Development expenses are related to the Security segment’s development of next generation solutions associated with security and surveillance systems software and the Aerospace and Defense segment’s development and improvement of their products.

 

Bargain Purchase Gain

 

As discussed in Note 1 of the Form 10-Q, the acquisition of Richland, LLC resulted in a bargain purchase gain of 2,068,047 based on the preliminary purchase price allocation. The purchase price allocation is still preliminary but has been developed based on an estimate of fair values of Richland’s identifiable tangible and intangible assets acquired and liabilities assumed as of February 5, 2026. The final allocation of the purchase price will be determined within one year from the closing date of the Invocon acquisition.

 

Other Income/Expense

 

Other income for the three months ended March 31, 2026, was $3,467,711, as compared to $4,104,211 for the three months ended March 31, 2025. Other income for the three months ended March 31, 2026, was mainly driven by the bargain purchase gain mentioned above, gain on the exercise of warrant liabilities and the change in the fair value of warrant liabilities, offset by interest expense and the change in the fair value of the Company’s digital assets. Other income for the three months ended March 31, 2025, was mainly driven by the change in the fair value of warrant liabilities.

 

Provision for Income Taxes

 

During the three months ended March 31, 2026, and 2025, the Company had income tax expense from continuing operations of $73,859 and $110,525, respectively. The provision for income tax is estimated based upon the current income projections of the Company, the effective rate of the prior year, and the Company’s current ability to utilize net loss carryforwards. The Company’s effective tax rate for the three months ended March 31, 2026, and 2025, was 5.7% and 1.27% respectively.

 

Results of Operations – For the six months ended March 31, 2026, and 2025

 

Revenues

 

The Company’s Security segment revenues for the six months ended March 31, 2026, decreased by $11,146,766 or 50% to $11,288,085 from $22,434,851 for the six months ended March 31, 2025. This decrease is mainly due to a large sale valued at $10,375,000 for security technology products under our Vicon brand during the quarter ended March 31, 2025.

 

35
 

 

The Company’s Industrial Services segment revenues for the six months ended March 31, 2026, increased by $3,093,885 or 17%, to $21,649,202 from $18,555,317, for the six months ended March 31, 2025. This increase is mainly due to the revenues from the acquisition of Richland LLC.

 

The Company’s newly established Aerospace and Defense segment generated revenues of $1,232,592 for the six months ended March 31, 2026

 

There was unallocated revenue under the Corporate segment of $24,799 for the six months ended March 31, 2026. This revenue is related to the Company’s investment in digital assets.

 

Gross Profit

 

Gross Profit for the six months ended March 31, 2026, was $12,469,070 or 36% of revenues as compared to gross profit of $17,867,391 or 44% of revenues for the six months ended March 31, 2025.

 

Gross profit in our Security segment was $4,691,462 or 42% of the segment’s revenues for the six months ended March 31, 2026, as compared to gross profit of $11,643,615 or 52% of the segment’s revenues for the period ended March 31, 2025. Gross profit in our security segment decreased as a result of the large sale mentioned above, additionally gross profits have been impacted by tariffs and fuel surcharges on shipping. The Company is currently evaluating the potential impact of tariff refunds on future gross profit percentages.

 

Gross profit in our Industrial Services segment was $7,231,994 or 33% of the segment’s revenues for the six months ended March 31, 2026, as compared to gross profit of $6,223,776 or 34% of the segment’s revenues for the period ended March 31, 2025. Gross profit increased in the six months ended March 31, 2026, compared to the six months ended March 31, 2025, was mainly due to the acquisition of Richland, LLC which lowered outsourcing costs now provided by AIS – TN, formerly Richland LLC.

 

Gross profit in the Company’s newly established Aerospace and Defense segment was 520,815 or 42% of revenues for the six months ended March 31, 2026

 

General and Administrative Expenses

 

General and administrative expenses for the six months ended March 31, 2026, increased $2,534,943 or 18% to $16,398,974 from $13,864,031 for the six months ended March 31, 2025. The increase in general and administrative expenses is mainly related to the additional expenses related to the acquisition of Invocon and Richland.

 

Research and Development Expenses

 

Research and Development expenses for the six months ended March 31, 2026, were $1,048,293 compared to $1,667,972 for the six months ended March 31, 2025, a decrease of $619,697or 37%. Research and Development expenses are related to the Security segment’s development of next generation solutions associated with security and surveillance systems software and the Aerospace and Defense segment’s development and improvement of their products.

 

Bargain Purchase Gain

 

As discussed in Note 1 of the Form 10-Q, the acquisition of Richland, LLC resulted in a bargain purchase gain of 2,068,047 based on the preliminary purchase price allocation. The purchase price allocation is still preliminary but has been developed based on an estimate of fair values of Richland’s identifiable tangible and intangible assets acquired and liabilities assumed as of February 5, 2026. The final allocation of the purchase price will be determined within one year from the closing date of the Invocon acquisition.

 

Other Income/Expense

 

Other expense for the six months ended March 31, 2026, was $14,047,941, as compared to $22,161,046 for the six months ended March 31, 2025. Other expense for the six months ended March 31, 2026, was mainly driven by the bargain purchase gain mentioned above, loss on the exercise of warrant liabilities, interest expense, and the change in the fair value of the Company’s digital assets. Other expense for the six months ended March 31, 2025, was mainly driven by the loss on excess fair value and change in the fair value of warrant liabilities.

 

36
 

 

Provision for Income Taxes

 

During the six months ended March 31, 2026, and 2025, the Company had income tax expense from continuing operations of $340,185 and $231,063, respectively. The provision for income tax is estimated based upon the current income projections of the Company, the effective rate of the prior year, and the Company’s current ability to utilize net loss carryforwards. The Company’s effective tax rate for the six months ended March 31, 2026, and 2025, was (1.79%) and (1.17%) respectively.

 

Effects of Inflation

 

The Company’s business and operations have been affected by inflation during the periods for which financial information is presented. In response, the Company has instituted price increases and initiated cost-saving measures to mitigate the effects of inflation on operations.

 

Liquidity and Capital Resources

 

Working capital was $13,706,571 at March 31, 2026, compared to working capital of $5,184,339 at September 30, 2025. This includes cash and cash equivalents and restricted cash of $7,910,118 at March 31, 2026, and $6,347,041 at September 30, 2025. The increase in working capital was primarily due to cash raised in the equity offerings and Series B Warrant exercises and the payment of the Company’s debt through equity.

 

Cash used by operating activities for the six months ended March 31, 2026, was $5,310,446 compared to providing $1,600,532 for the six months ended March 31, 2025. Our operating cash flow was mainly the result of our net loss, less the non-cash adjustments, combined with operating changes in contract assets, prepaid expenses and other current assets, accounts payable, operating lease liabilities, accrued expenses, and deferred revenues.

 

Trade receivables increased by $192,135 or 1% to $13,325,559 at March 31, 2026, from $13,133,424 at September 30, 2025. The modest increase in trade receivables is attributable to the acquisitions of Richland and Invocon.

 

Cash used by investing activities for the six months ended March 31, 2026, was $13,972,452 compared to $1,436,452 for the three months ended March 31, 2025. Investing activities for the six months ended March 31, 2026, were driven by the Company’s purchase of property and equipment, investment in marketable securities, the acquisition of Richland and Invocon, and investment in digital assets. Investing activities for the six months ended March 31, 2025, were driven by the Company’s purchase of property and equipment and investment in Masterpiece VR.

 

Cash provided by financing activities for the six months ended March 31, 2026, was $20,871,752 compared to $1,032,254 for the six months ended March 31, 2025. Financing activities for the six months ended March 31, 2026, were primarily driven by the proceeds from equity offerings, proceeds of notes payable, and proceeds from the exercise of the Company’s Series B Warrants. Financing activities for the six months ended March 31, 2025, were primarily driven by the proceeds from the Company’s revolving line of credit, notes payable, and proceeds from the exercise of the Company’s Series B Warrants.

 

The Company’s working capital may not be sufficient to cover operating costs which indicates substantial doubt regarding the Company’s ability to continue as a going concern, the Company has historically, from time to time, satisfied and may continue to satisfy certain short-term liabilities through the issuance of common stock, thus reducing our cash requirement to meet our operating needs. The Company has $7,910,118 in cash and cash equivalents and restricted cash as of March 31, 2026. Additionally, the Company has (i) secured a line of credit for its Vicon brand to fund operations, which as of March 31, 2026, has available capacity of approximately $1,100,000, (ii) continually reevaluate our pricing model on our Vicon brand to improve margins on those products, (iii) raised $5,675,332 through the exercise of our Series B warrants during the six months ended March 31, 2026 (iv) raised $10,000,000 in gross proceeds in equity offering during the six months ended March 31, 2026 (v) Invested approximately $5,000,000 of the Company’s surplus cash in various marketable securities to generate income on those investments.

 

In the event additional capital is raised through equity offerings and/or debt is satisfied with equity, it may have a dilutive effect on our existing stockholders. While the Company believes these plans, if successful, would be sufficient to meet the capital demands of our current operations for at least the next twelve months, there is no guarantee that we will succeed. Overall, there is no guarantee that cash flow from our existing or future operations and any external capital that we may be able to raise will be sufficient to meet our working capital needs. The Company currently does not have adequate cash or available liquidity/available capacity on our lines of credit to meet our short or long-term needs. Absent an ability to raise additional outside capital and restructure or refinance all or a portion of our debt, the Company will be unable to meet its obligations as they become due over the next twelve months beyond the issuance date.

 

Each segment of the Company’s operations has positioned itself for growth and the Company’s long-term objectives include increasing marketing and sales for the Company’s products and services in each segment, increasing the Company’s presence through collaboration partnerships in each segment and through strategic acquisitions of complementary businesses for each segment. These long-term objectives will require sufficient cash to complete, and the Company expects to fund these objectives with cash on hand, issuance of debt, and from proceeds from the sale of the Company’s securities, which may not be sufficient to fully implement our growth initiatives.

 

The unaudited condensed consolidated financial statements do not include any adjustments relating to this uncertainty.

 

37
 

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures reporting as promulgated under the Exchange Act is defined as controls and procedures that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act are recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms. Disclosure controls and procedures include without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

Our CEO and our CFO have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2026. Based on their evaluation, our management has concluded that as of March 31, 2026, our disclosure controls and procedures were effective.

 

Changes in Internal Control Over Financial Reporting

 

There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) that occurred during the three months ended March 31, 2026, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Limitations on the Effectiveness of Controls

 

Our management, including our CEO and CFO, does not expect that our disclosure controls and procedures or our internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected.

 

38
 

 

Part II Other Information

 

Item 1. Legal Proceedings.

 

To the Company’s knowledge, there is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our Company or any of our subsidiaries, threatened against or affecting our Company, our common stock, any of our subsidiaries or of our Company’s or our Company’s subsidiaries’ officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect.

 

Item 1A. Risk Factors

 

Our business faces many risks, a number of which are described in the section captioned “Risk Factors” in our Annual Report for the year ended September 30, 2025, filed with the SEC on December 29, 2025, and amended on January 16, 2026. The risks described may not be the only risks we face. Other risks of which we are not yet aware, or that we currently believe, are not material, may also materially and adversely impact our business operations or financial results. If any of the events or circumstances described in the risk factors contained in our Annual Report or Quarterly Report occur, our business, financial condition or results of operations could be adversely impacted and the value of an investment in our securities could decline. Investors and prospective investors should consider the risks described in our Annual Report and Quarterly Reports, and the information contained in the section captioned “Forward-Looking Statements” and elsewhere in this Quarterly Report before deciding whether to invest in our securities.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

Preferred Stock

 

During the six months ended March 31, 2026, 135,592 shares of Series 1 Preferred Stock were issued to pay dividends to holders of Series 1 Preferred Stock.

 

Common Stock

 

During the six months ended March 31, 2026, 3,000,296 shares of the Company’s common stock have been issued to satisfy $7,728,163 of notes payable, $115,837 in accrued interest, and $11,798,283 of excess value of shares issued recorded as interest expense. Such shares were issued pursuant to the exemption contained under Section 4(a)(2) of the Securities Act of 1933, as amended.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

N/A

 

Item 5. Other Information

 

None.

 

39
 

 

Item 6. Exhibits

 

Exhibit       Incorporated by
Reference
  Filed or
Furnished
 
Number   Exhibit Description   Form   Filing Date   Herewith
2.1   Stock Purchase Agreement, dated December 15, 2015   Form 8-K/A   9/26/2016    
2.2   Asset Purchase Agreement, between AIS Tennessee, Inc., Richland Industries, LLC, and Joseph Wheland   Form 8-K   2/11/2026    
2.3   Share Purchase Agreement, dated November 13, 2025   Form 8-K   11/19/2025    
3.1   Certificate of Incorporation filed with the State of Delaware.   Form 10-12G   5/22/2008    
3.2   Bylaws   Form 10-12G   5/22/2008    
3.3   Amendment to Certificate of Incorporation   Form 10-12G   5/22/2008    
3.4   Amendment to Certificate of Incorporation   Form 10-12G   5/22/2008    
3.5   Amendment to Certificate of Incorporation   Form 10-12G   5/22/2008  
3.6   Amendment to Certificate of Incorporation   Form 10-12G   5/22/2008    
3.7   Amendment to Certificate of Incorporation   Form 8-K   8/22/2016    
3.8   Amendment to Certificate of Incorporation   Form 8-K   9/30/2024    
3.9   Amendment to Certificate of Incorporation   Form 8-K   11/21/2024    
3.10   Amendment to Certificate of Incorporation   Form 8-K   9/24/2025    
3.11   Certificate of Designation of the Series A Preferred Shares   Form 8-K   9/10/2009    
3.12   Certificate of Designation of the Series 1 Preferred Shares   Form 8-K   1/24/2017    
3.13   Amendment to Certificate of Incorporation   Form 8-K   9/8/2017    
3.14   Certificate of Correction to the Certificate of Amendment   Form 8-K   6/12/2019    
3.15   Amended Certificate of Designation of the Series 1 Preferred Shares   Form 8-K   4/1/2020    
3.16   Amendment to Certificate of Incorporation   Form 10-K   1/5/2021    
3.17   Certificate of Correction to the Certificate of Amendment   Form 10-Q   5/28/2021    
3.18   Amendment to Certificate of Incorporation   Form 8-K   1/20/2023    
3.19   Amendment to Certificate of Incorporation   Form 8-K   8/2/2024    
10.20   Amendment to Certificate of Incorporation   Form 8-K   9/30/2024    
10.21   Amendment to Certificate of Incorporation   Form 8-K   11/21/2024    
10.22   Amendment to Certificate of Incorporation   Form 8-K   9/24/2025    
4.1   Form of Subscription Rights Certificate   Form S-1   8/29/2016    
4.2   Form of Series 1 Preferred Stock Certificate   Form S-1/A   11/23/2016    
4.3   Form of Series 1 Warrant   Form S-1/A   12/7/2016    
4.4   Form of Common Stock Purchase Warrant   Form 8-K   3/22/2019    
4.5   Form of Prefunded Warrant   Form 8-K   5/3/2024    
4.6   Form of Series A Common Stock Purchase Warrant   Form 8-K   5/3/2024    
4.7   Form of Series B Common Stock Purchase Warrant   Form 8-K   5/3/2024    
5.1   Opinion of the Doney Law Firm   Form S-1/A   4/30/2024    
10.1   Underwriting Agreement, dated May 28, 2025 with Aegis Capital Corp.   Form 8-K   5/29/2025    
10.2   Securities Purchase Agreement, dated December 11, 2025   Form 8-K   12/11/2025    
10.3   Securities Purchase Agreement, dated December 23, 2025   Form 8-K   12/23/2025    
10.4   Securities Purchase Agreement, dated January 9, 2026   Form 8-K   1/9/2026    
10.5   Sales Agreement between AIS Leasing Company and RI Real Estate, LLC   Form 8-K   2/11/2026    
21.1   Subsidiaries of the Registrant           X
31.1   Certification of Chief Executive Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.           X
31.2   Certification of Interim Chief Financial Officer and Principal Financial Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.           X
32.1   Certification of Chief Executive Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act 0f of 2002.           X
32.2   Certification of Interim Chief Financial Officer and Principal Financial Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act 0f of 2002.           X
97.1   Clawback Policy   Form 10-K   12/29/2025    
99.1   Order pursuant to Section 8A of the Securities Act – dated September 30, 2022.   Form 8-K   10/4/2022    
101.INS   Inline XBRL Instance Document           X
101.SCH   Inline XBRL Taxonomy Extension Schema           X
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase           X
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase           X
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase           X
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase           X
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)           X

 

40
 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

   Cemtrex, Inc.
     
Dated: May 15, 2026  By: /s/ Saagar Govil .
    Saagar Govil
    Chairman of the Board, CEO,
    President and Secretary (Principal Executive Officer)
     
Dated: May 15, 2026   /s/ Paul J. Wyckoff .
    Paul J. Wyckoff
    Chief Financial Officer and Principal Financial Officer

 

41

 

FAQ

How did Cemtrex (CETX) perform financially in Q2 2026?

Cemtrex generated $18.1 million in revenue and net income of $907,048 for the quarter ended March 31, 2026. This compares with $27.3 million in revenue and $8.6 million of net income in the prior‑year quarter, reflecting lower sales and a greater role for non‑operating items.

What were Cemtrex’s results for the first six months of fiscal 2026?

For the six months ended March 31, 2026, Cemtrex reported revenue of $34.2 million and a net loss of $19.6 million. In the comparable 2025 period, revenue was $41.0 million with a net loss of $20.3 million, indicating continued significant losses despite some non‑cash items.

What acquisitions did Cemtrex (CETX) complete in early 2026?

On January 8, 2026, Cemtrex acquired Invocon, Inc. for $7.06 million in cash, recording $3.98 million of goodwill and $3.13 million of intangibles. On February 5, 2026, it bought Richland Industries’ assets with total preliminary consideration of $5.44 million and recognized a $2.07 million bargain purchase gain.

Why does Cemtrex’s 10-Q include a going concern warning?

Management notes substantial doubt about Cemtrex’s ability to continue as a going concern due to large recurring net losses, including $28.1 million in fiscal 2025 and $19.6 million in the first half of 2026, plus debt obligations of $10.8 million coming due within the next fiscal year.

How much liquidity does Cemtrex (CETX) report as of March 31, 2026?

Cemtrex reports $7.91 million in cash, cash equivalents, and restricted cash at March 31, 2026, along with approximately $1.1 million of available capacity on a Vicon revolving credit line. It also holds $5.03 million of marketable securities and $1.09 million in Solana digital assets at fair value.

What new debt did Cemtrex incur to fund its strategy?

On November 7, 2025, Cemtrex issued a $7.03 million note to Streeterville Capital with an additional one‑time interest fee of $1.05 million. On February 5, 2026, it added a $600,000 note and a $3.92 million mortgage with Fulton Bank to finance the Richland acquisition and related facility.

How many Cemtrex (CETX) shares are outstanding after recent issuances?

Cemtrex had 10,078,089 common shares issued and outstanding as of March 31, 2026, up from 830,606 at September 30, 2025. Subsequent activity further increased the count to 11,121,834 shares of common stock outstanding as of May 13, 2026, reflecting offerings and warrant exercises.